To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene ANXA2TABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
1106 representative clones for gene ANXA2 back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
BM794393 Ascites, stomach .a 1 to 526 1 to 526   tiling clone,   526/526
(100 %)
2 diff
(99.7 %id)
AA307115 colon .a 14 to 544 1 to 531       531/531
(100 %)
1 diff
(99.9 %id)
AW957778   .a 15 to 637 1 to 623   tiling clone,   623/624
(99 %)
4 diff
(99.4 %id)
BQ876604 hepatocellular carcinoma, cell line, Liver .a 65 to 895 1 to 837       837/889
(94 %)
11 diff
(98.8 %id)
BQ064513 lymph, lymphoma, cell line .a 69 to 796 1 to 733       733/1053
(69 %)
16 diff
(98.5 %id)
BU162542 hepatocellular carcinoma, cell line, Liver .a 69 to 951 1 to 884       884/1088
(81 %)
5 diff
(99.6 %id)
BQ651454 hepatocellular carcinoma, cell line, Liver .a 69 to 959 1 to 896       896/968
(92 %)
17 diff
(98.3 %id)
BQ652885 hepatocellular carcinoma, cell line, Liver .a 69 to 895 1 to 830       830/910
(91 %)
17 diff
(98.2 %id)
ES310327 scalp interfollicular dermis, skin .a 101 to 732 22 to 652       631/874
(72 %)
9 diff
(99.0 %id)
ES310643 scalp interfollicular dermis, skin .a 102 to 420 1 to 320       320/320
(100 %)
2 diff
(99.4 %id)
BU168464 ductal carcinoma, cell line, Pancreas .a 107 to 951 1 to 855       855/1042
(82 %)
17 diff
(98.4 %id)
BU174685 ductal carcinoma, cell line, Pancreas .a 107 to 796 1 to 692       692/987
(70 %)
21 diff
(97.9 %id)
BQ897124 ductal carcinoma, cell line, Pancreas .a 107 to 951 1 to 856       856/896
(95 %)
16 diff
(98.3 %id)
BQ686710 ductal carcinoma, cell line, Pancreas .a 107 to 959 1 to 860       860/965
(89 %)
10 diff
(99.0 %id)
BQ686675 ductal carcinoma, cell line, Pancreas .a 107 to 903 1 to 798       798/882
(90 %)
9 diff
(99.0 %id)
TI_1948224985   .a 116 to 895 128 to 915       788/1058
(74 %)
22 diff
(98.0 %id)
TI_1948225641   .a 116 to 903 125 to 909       785/1426
(55 %)
25 diff
(98.3 %id)
TI_1948225642   .a 116 to 888 126 to 902       777/1051
(73 %)
20 diff
(98.1 %id)
AW840175 leiomios .a 144 to 260 123 to 10       114/123
(92 %)
0 diff
(100 %id)
CN407802 embryonic stem cells, cell lines H1, H7, andH9 .a 157 to 726 1 to 571       571/571
(100 %)
1 diff
(99.9 %id)
CN407857 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a 157 to 782 1 to 629       629/629
(100 %)
4 diff
(99.4 %id)
CN407864 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a 157 to 721 1 to 565       565/565
(100 %)
0 diff
(100 %id)
CN407873 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a 157 to 754 1 to 598       598/598
(100 %)
0 diff
(100 %id)
CN407932 embryonic stem cells, cell lines H1, H7, andH9 .a 157 to 628 1 to 472       472/472
(100 %)
0 diff
(100 %id)
CN407939 embryonic stem cells, cell lines H1, H7, andH9 .a 157 to 754 1 to 598       598/598
(100 %)
0 diff
(100 %id)
CN407946 embryonic stem cells, cell lines H1, H7, andH9 .a 157 to 580 1 to 424       424/424
(100 %)
1 diff
(99.8 %id)
BG028513 Bone, osteosarcoma, cell line .a 157 to 893 1 to 724       724/951
(76 %)
18 diff
(98.2 %id)
CD617844   .a 164 to 959 828 to 31       798/834
(95 %)
11 diff
(98.7 %id)
BG112708 Bone, osteosarcoma, cell line .a 164 to 898 1 to 737       737/1053
(69 %)
14 diff
(98.7 %id)
BG748742 eye, normal pigmented retinal epithelium .a 165 to 883 1 to 718       718/862
(83 %)
18 diff
(98.0 %id)
CN407878 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a 166 to 452 1 to 287       287/287
(100 %)
0 diff
(100 %id)
BE746291 adenocarcinoma cell line, ovary .a 169 to 833 1 to 663       663/663
(100 %)
2 diff
(99.7 %id)
CU456874 epidermis .a 171 to 731 589 to 29     Submitted on the opposite strand 561/606
(92 %)
2 diff
(99.7 %id)
AA352257   .a 175 to 354 1 to 180       180/180
(100 %)
0 diff
(100 %id)
AA352527   .a 175 to 310 1 to 136       136/136
(100 %)
0 diff
(100 %id)
CB265678 adipose .a 176 to 807 1 to 633       633/633
(100 %)
4 diff
(99.4 %id)
ES314194 occipital scalp hair, skin .a 180 to 334 1 to 155       155/155
(100 %)
0 diff
(100 %id)
CB134181 Liver .a 181 to 755 1 to 575       575/575
(100 %)
1 diff
(99.9 %id)
CB135452 Liver .a 181 to 527 1 to 347       347/347
(100 %)
0 diff
(100 %id)
BG752642 eye, normal pigmented retinal epithelium .a 182 to 893 1 to 713       713/818
(87 %)
8 diff
(99.1 %id)
BE740122 adenocarcinoma cell line, ovary .a 183 to 958 1 to 773       773/861
(89 %)
19 diff
(97.8 %id)
CD617842   .a 184 to 959 807 to 31   tiling clone,   777/825
(94 %)
5 diff
(99.4 %id)
AA384258 thyroid gland .a 185 to 488 1 to 304       304/304
(100 %)
0 diff
(100 %id)
BG939108 Bone, Hip .a 188 to 832 1 to 645       645/645
(100 %)
6 diff
(99.1 %id)
BM010624 amelanotic melanoma, cell line, skin .a 189 to 783 1 to 591       591/591
(100 %)
4 diff
(99.4 %id)
CN485294 eye .a 194 to 836 1 to 643       643/643
(100 %)
0 diff
(100 %id)
BE336948 adenocarcinoma cell line, ovary .a 196 to 871 1 to 675       675/681
(99 %)
5 diff
(99.3 %id)
CV574440 cornea, eye .a 197 to 825 1 to 629       629/629
(100 %)
0 diff
(100 %id)
BI090247 cervix .a 201 to 893 1 to 695       695/906
(76 %)
8 diff
(99.2 %id)
CB149022 Liver .a 201 to 772 1 to 572       572/572
(100 %)
3 diff
(99.5 %id)
CB142418 Liver .a 202 to 725 1 to 524       524/524
(100 %)
0 diff
(100 %id)
CB148630 Liver .a 203 to 783 1 to 581       581/581
(100 %)
0 diff
(100 %id)
BG546646 lung .a 204 to 887 1 to 678       678/678
(100 %)
7 diff
(99.0 %id)
CB149326 Liver .a 206 to 742 1 to 537       537/537
(100 %)
4 diff
(99.3 %id)
FN165159 breast carcinoma .a 207 to 293 95 to 9     Submitted on the opposite strand 87/95
(91 %)
1 diff
(99.0 %id)
CD518334 White Matter .a 208 to 951 1 to 750       750/833
(90 %)
7 diff
(99.2 %id)
CB215916 normal endometrium, late proliferativephase, cycle day 13, uterus .a 217 to 834 1 to 618       618/618
(100 %)
0 diff
(100 %id)
BI334607 cervical carcinoma cell line, cervix .a 220 to 857 1 to 638       638/638
(100 %)
0 diff
(100 %id)
CB105688 Liver .a 221 to 636 1 to 416       416/416
(100 %)
1 diff
(99.8 %id)
BE718995 head_neck .a 222 to 712 1 to 490       490/492
(99 %)
2 diff
(99.6 %id)
BM043650 carcinoma, cell line, Prostate .a 222 to 851 1 to 636       636/773
(82 %)
11 diff
(98.6 %id)
BG282806 adenocarcinoma, cell line, Prostate .a 225 to 899 1 to 674       674/1082
(62 %)
11 diff
(99.0 %id)
CB113140 Liver .a 226 to 527 1 to 302       302/302
(100 %)
0 diff
(100 %id)
BF036763 adenocarcinoma, ovary .a 227 to 855 1 to 629       629/629
(100 %)
4 diff
(99.4 %id)
CB216858 normal endometrium, mid-secretory phase,cycle day 23, uterus .a 230 to 872 1 to 643       643/643
(100 %)
0 diff
(100 %id)
CB123142 Liver .a 230 to 632 1 to 403       403/403
(100 %)
0 diff
(100 %id)
CB122683 Liver .a 231 to 760 530 to 1     Submitted on the opposite strand 530/530
(100 %)
0 diff
(100 %id)
BM738972 Ascites, stomach .a 232 to 742 1 to 509       509/509
(100 %)
3 diff
(99.5 %id)
AA303769 aorta .a 234 to 483 1 to 250       250/250
(100 %)
0 diff
(100 %id)
AA303445 aorta .a 235 to 577 1 to 343       343/343
(100 %)
1 diff
(99.8 %id)
CB149922 Liver .a 235 to 789 1 to 556       556/556
(100 %)
3 diff
(99.5 %id)
BE394724 endometrium, adenocarcinoma cell line, uterus .a 237 to 868 1 to 629       629/632
(99 %)
6 diff
(99.1 %id)
BG497774 adenocarcinoma, Prostate .a 237 to 903 1 to 662       662/733
(90 %)
14 diff
(98.1 %id)
AA303542 aorta .a 239 to 604 1 to 368       368/368
(100 %)
2 diff
(99.5 %id)
CB120007 Liver .a 239 to 636 1 to 398       398/398
(100 %)
3 diff
(99.3 %id)
CB130204 Liver .a 241 to 846 1 to 606       606/606
(100 %)
0 diff
(100 %id)
BM740751 Ascites, stomach .a 241 to 760 1 to 520       520/520
(100 %)
0 diff
(100 %id)
BM830844 stomach .a 241 to 788 1 to 548       548/548
(100 %)
0 diff
(100 %id)
BP420831 small intestine .a 246 to 744 1 to 499     Submitted on the opposite strand 499/499
(100 %)
0 diff
(100 %id)
BG290829 bladder, transitional cell papilloma, cell line .a 248 to 945 1 to 699       699/699
(100 %)
7 diff
(99.0 %id)
BM790310 Ascites, stomach .a 248 to 771 1 to 523       523/523
(100 %)
2 diff
(99.7 %id)
CB107196 Liver .a 252 to 742 1 to 491       491/491
(100 %)
0 diff
(100 %id)
CN407826 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a 255 to 891 1 to 637       637/637
(100 %)
0 diff
(100 %id)
CB118089 Liver .a 263 to 713 1 to 451       451/451
(100 %)
0 diff
(100 %id)
BE394394 endometrium, adenocarcinoma cell line, uterus .a 264 to 656 1 to 393       393/395
(99 %)
1 diff
(99.8 %id)
CB119471 Liver .a 275 to 845 1 to 571       571/571
(100 %)
0 diff
(100 %id)
CB122124 Liver .a 275 to 718 1 to 444       444/444
(100 %)
1 diff
(99.8 %id)
AA371451 Prostate .a 279 to 512 1 to 234       234/234
(100 %)
0 diff
(100 %id)
CB132797 Liver .a 282 to 949 1 to 668       668/668
(100 %)
0 diff
(100 %id)
AA313761 colon .a 283 to 739 1 to 457       457/457
(100 %)
0 diff
(100 %id)
BM798625 myeloma .a 289 to 778 1 to 490       490/490
(100 %)
1 diff
(99.8 %id)
BM770367 Ascites, stomach .a 294 to 891 1 to 595       595/595
(100 %)
1 diff
(99.9 %id)
BM771539 Ascites, stomach .a 294 to 786 1 to 493       493/493
(100 %)
0 diff
(100 %id)
BM771083 Ascites, stomach .a 294 to 837 1 to 544       544/544
(100 %)
0 diff
(100 %id)
BG779483 adenocarcinoma, Prostate .a 299 to 848 1 to 550       550/550
(100 %)
1 diff
(99.9 %id)
CB119571 Liver .a 301 to 749 1 to 449       449/449
(100 %)
2 diff
(99.6 %id)
BM823675 Ascites, stomach .a 313 to 803 1 to 491       491/491
(100 %)
0 diff
(100 %id)
BE766189 nervous_tumor .a 315 to 571 1 to 257       257/258
(99 %)
6 diff
(97.7 %id)
BE766497 nervous_tumor .a 315 to 571 1 to 257       257/258
(99 %)
6 diff
(97.7 %id)
BM705045 eye, lens .a 315 to 751 1 to 437       437/437
(100 %)
1 diff
(99.8 %id)
BM845932 myeloma .a 318 to 766 1 to 449       449/449
(100 %)
0 diff
(100 %id)
BF725567 eye, Iris .a 320 to 847 1 to 528       528/528
(100 %)
0 diff
(100 %id)
BF725994 eye, Iris .a 320 to 725 1 to 406       406/406
(100 %)
0 diff
(100 %id)
CB132192 Liver .a 320 to 845 1 to 526       526/526
(100 %)
1 diff
(99.9 %id)
CD617840   .a 322 to 959 669 to 31       639/669
(95 %)
1 diff
(99.9 %id)
AA082247   .a 322 to 637 1 to 317       317/317
(100 %)
1 diff
(99.7 %id)
CN407849 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a 324 to 596 1 to 273       273/273
(100 %)
0 diff
(100 %id)
BG982628 colon_normal .a 325 to 722 1 to 398       398/398
(100 %)
1 diff
(99.8 %id)
BG984834 colon_normal .a 325 to 764 1 to 440       440/440
(100 %)
1 diff
(99.8 %id)
BG984965 colon_normal .a 325 to 745 1 to 421       421/421
(100 %)
2 diff
(99.6 %id)
AA303975 aorta .a 326 to 659 1 to 335       335/335
(100 %)
1 diff
(99.8 %id)
CB118795 Liver .a 328 to 783 1 to 457       457/457
(100 %)
1 diff
(99.8 %id)
CU455391 epidermis .a 329 to 722 394 to 1     Submitted on the opposite strand 394/394
(100 %)
2 diff
(99.5 %id)
BM765335 Ascites, stomach .a 329 to 837 1 to 508       509/508
(100 %)
2 diff
(99.7 %id)
BM797651 Ascites, stomach .a 331 to 725 1 to 395       395/395
(100 %)
0 diff
(100 %id)
AA186378   .a 342 to 770 1 to 433       431/434
(99 %)
4 diff
(99.1 %id)
CB114570 Liver .a 343 to 847 1 to 505       505/505
(100 %)
0 diff
(100 %id)
CB122057 Liver .a 343 to 720 1 to 377       379/377
(100 %)
2 diff
(99.5 %id)
CB120246 Liver .a 343 to 870 1 to 528       528/528
(100 %)
1 diff
(99.9 %id)
CB123918 Liver .a 343 to 799 1 to 457       457/457
(100 %)
0 diff
(100 %id)
BP387369 pancreatic islet .a 346 to 840 495 to 1       495/500
(99 %)
0 diff
(100 %id)
CB121620 Liver .a 352 to 847 1 to 496       496/496
(100 %)
0 diff
(100 %id)
BG977463 colon_ins .a 356 to 785 1 to 430       430/430
(100 %)
0 diff
(100 %id)
BM840833 myeloma .a 357 to 944 1 to 588       588/588
(100 %)
2 diff
(99.7 %id)
CB133900 Liver .a 358 to 943 1 to 586       586/586
(100 %)
0 diff
(100 %id)
BM798923 stomach .a 362 to 949 1 to 588       588/588
(100 %)
1 diff
(99.9 %id)
BM825602 stomach .a 362 to 742 1 to 381       381/381
(100 %)
1 diff
(99.8 %id)
BM751796 Ascites, stomach .a 375 to 865 1 to 491       491/491
(100 %)
0 diff
(100 %id)
BM705904 eye, lens .a 385 to 907 1 to 523       523/523
(100 %)
0 diff
(100 %id)
BM017736 astrocytoma grade IV, cell line, brain .a 392 to 952 1 to 561       561/561
(100 %)
1 diff
(99.9 %id)
CB117463 Liver .a 402 to 845 1 to 444       444/444
(100 %)
0 diff
(100 %id)
CB141972 Liver .a 402 to 770 1 to 369       369/369
(100 %)
1 diff
(99.8 %id)
CB133414 Liver .a 402 to 762 1 to 362       362/362
(100 %)
1 diff
(99.8 %id)
CB118806 Liver .a 410 to 790 1 to 381       381/381
(100 %)
2 diff
(99.5 %id)
BE718187 head_neck .a 419 to 908 506 to 17       490/506
(96 %)
0 diff
(100 %id)
CB116143 Liver .a 423 to 948 1 to 526       526/526
(100 %)
3 diff
(99.5 %id)
BM785105 Ascites, stomach .a 430 to 788 1 to 359       359/359
(100 %)
0 diff
(100 %id)
BM753380 Ascites, stomach .a 431 to 953 1 to 523       523/526
(99 %)
2 diff
(99.7 %id)
AA309142 aorta .a 437 to 770 1 to 334       334/334
(100 %)
1 diff
(99.8 %id)
CN407875 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 440 to 899 1 to 460       460/460
(100 %)
3 diff
(99.4 %id)
BM796649 Ascites, stomach .a 441 to 854 1 to 414       414/414
(100 %)
2 diff
(99.6 %id)
AA370720 Prostate .a 444 to 761 1 to 321       321/321
(100 %)
3 diff
(99.1 %id)
AA304540 aorta .a 445 to 723 1 to 279       279/279
(100 %)
0 diff
(100 %id)
AJ714423 bone marrow .a 445 to 827 1 to 383       383/383
(100 %)
0 diff
(100 %id)
BM852330 Ascites, stomach .a 460 to 949 1 to 490       490/490
(100 %)
1 diff
(99.8 %id)
BM832269 stomach .a 466 to 811 1 to 345       345/345
(100 %)
1 diff
(99.8 %id)
BM821550 stomach .a 471 to 950 7 to 485       479/485
(98 %)
6 diff
(98.8 %id)
BQ308631 breast .a 479 to 819 1 to 341       339/341
(99 %)
2 diff
(99.5 %id)
AA302389.
matches multiple genes
aorta .a 480 to 649 1 to 170     also hits gene ANXA2P2 170/170
(100 %)
0 diff
(100 %id)
BF999179 placenta_normal .a 480 to 903 441 to 18       424/455
(93 %)
1 diff
(99.8 %id)
AA304496 aorta .a 483 to 776 1 to 294       294/294
(100 %)
0 diff
(100 %id)
ES308276 beard hair, skin .a 483 to 741 1 to 259       259/259
(100 %)
0 diff
(100 %id)
AA303776 aorta .a 488 to 747 1 to 260       260/260
(100 %)
0 diff
(100 %id)
AA304360.
matches multiple genes
aorta .a 491 to 665 1 to 175     also hits gene ANXA2P2 175/175
(100 %)
0 diff
(100 %id)
BG982319 colon_normal .a 496 to 893 1 to 397       397/397
(100 %)
3 diff
(99.3 %id)
AA304017 aorta .a 501 to 776 1 to 276       276/276
(100 %)
0 diff
(100 %id)
CB123154 Liver .a 511 to 903 1 to 393       393/393
(100 %)
0 diff
(100 %id)
AA304935 colon .a 512 to 841 1 to 331       331/331
(100 %)
3 diff
(99.1 %id)
BM821757 stomach .a 527 to 879 1 to 352       352/352
(100 %)
1 diff
(99.8 %id)
BM831777 stomach .a 527 to 785 1 to 259       259/259
(100 %)
0 diff
(100 %id)
BM834657 stomach .a 527 to 868 1 to 342       342/342
(100 %)
0 diff
(100 %id)
AA303816 aorta .a 538 to 767 1 to 230       230/230
(100 %)
0 diff
(100 %id)
ES311339 frontal balding hair, skin .a 538 to 726 1 to 189       189/189
(100 %)
0 diff
(100 %id)
AA304418 aorta .a 558 to 776 1 to 219       219/219
(100 %)
0 diff
(100 %id)
AW392441 stomach .a 583 to 842 260 to 1       260/260
(100 %)
2 diff
(99.3 %id)
BM799139 Ascites, stomach .a 584 to 949 1 to 366       366/366
(100 %)
3 diff
(99.2 %id)
BE071955 breast .a 620 to 920 303 to 3     Submitted on the opposite strand 301/303
(99 %)
2 diff
(99.4 %id)
BE071995 breast .a 620 to 920 303 to 3     Submitted on the opposite strand 301/303
(99 %)
2 diff
(99.4 %id)
AA303206 aorta .a 638 to 776 1 to 139       139/139
(100 %)
0 diff
(100 %id)
TI_154098410   .a 689 to 1397 793 to 85   tiling clone, AAA   709/709
(100 %)
2 diff
(99.8 %id)
CA441006 Chondrosarcoma, Left Pubic Bone .a 710 to 1397 706 to 19   AAA   688/688
(100 %)
2 diff
(99.8 %id)
BE763506 nervous_tumor .a 829 to 963 144 to 5       145/144
(100 %)
5 diff
(96.6 %id)
NM_001002858.2   .b 1 to 1632 1 to 1632 exact RefSeq,   1632/1632
(100 %)
6 diff
(99.7 %id)
BX640598 colon endothel, primary cell culture .b 2 to 1440 1 to 1439 D184G tiling clone, available from DKFZ, AAA   1439/1439
(100 %)
4 diff
(99.8 %id)
CR622682 placenta .b 9 to 1449 1 to 1441 exact tiling clone,   1441/1441
(100 %)
0 diff
(100 %id)
CN407882 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .b 13 to 513 1 to 501       501/501
(100 %)
5 diff
(99.1 %id)
AA159250 Pancreas .b 17 to 465 1 to 455       455/456
(99 %)
10 diff
(97.9 %id)
BE747621 adenocarcinoma cell line, ovary .b 19 to 756 1 to 754       702/754
(93 %)
37 diff
(95.1 %id)
CN407937 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .b 20 to 738 1 to 719       719/719
(100 %)
6 diff
(99.2 %id)
CX166445 human embryonic stem cells differentiated toan early endodermal cell type .b 21 to 809 1 to 789       789/789
(100 %)
1 diff
(99.9 %id)
DR763554 embryonic stem .b 35 to 850 1 to 816       816/816
(100 %)
1 diff
(99.9 %id)
TI_57175610   .b 57 to 848 20 to 805       786/806
(97 %)
13 diff
(98.4 %id)
BG325643 Kidney, renal cell adenocarcinoma .b 59 to 814 1 to 746       746/898
(83 %)
18 diff
(98.0 %id)
BG327693 Kidney, renal cell adenocarcinoma .b 59 to 796 1 to 737       737/737
(100 %)
11 diff
(98.6 %id)
BI831729 brain, medulla .b 72 to 848 1 to 771       771/772
(99 %)
9 diff
(98.9 %id)
AA159153 Pancreas .b 1000 to 1440 442 to 1       442/442
(100 %)
5 diff
(98.9 %id)
BC093056 Blood vessels- blood vessel, aorta, basilarartery. .c 1 to 1470 1 to 1470 exact tiling clone, AAA   1470/1470
(100 %)
0 diff
(100 %id)
NM_001136015.2   .c 1 to 1665 1 to 1665 exact RefSeq,   1665/1665
(100 %)
6 diff
(99.7 %id)
CR597222 Neuroblastoma Cot 10-normalized .c 14 to 1454 1 to 1441 exact     1441/1441
(100 %)
0 diff
(100 %id)
BQ689932 ductal carcinoma, cell line, Pancreas .c 14 to 886 1 to 875       875/875
(100 %)
3 diff
(99.7 %id)
CB123500 Liver .c 21 to 626 1 to 606       606/606
(100 %)
0 diff
(100 %id)
CR618374 Neuroblastoma Cot 50-normalized .c 149 to 1429 1 to 1281 exact     1281/1281
(100 %)
0 diff
(100 %id)
BC052558 Pancreas, ductal carcinoma .c 150 to 1473 1 to 1324 exact available from MGC, AAA   1324/1324
(100 %)
0 diff
(100 %id)
BU169153 ductal carcinoma, cell line, Pancreas .c 152 to 1120 1 to 976       977/978
(99 %)
20 diff
(98.0 %id)
BQ686482 ductal carcinoma, cell line, Pancreas .c 152 to 1112 1 to 966       966/966
(100 %)
15 diff
(98.5 %id)
BQ689764 ductal carcinoma, cell line, Pancreas .c 152 to 1025 1 to 874       874/877
(99 %)
9 diff
(99.0 %id)
BQ686105 ductal carcinoma, cell line, Pancreas .c 152 to 1089 1 to 945       945/946
(99 %)
16 diff
(98.4 %id)
BQ691301 ductal carcinoma, cell line, Pancreas .c 152 to 1037 1 to 891       891/896
(99 %)
7 diff
(99.3 %id)
BQ687032 ductal carcinoma, cell line, Pancreas .c 152 to 1043 1 to 894       894/897
(99 %)
6 diff
(99.4 %id)
BQ688807 ductal carcinoma, cell line, Pancreas .c 152 to 1081 1 to 942       940/947
(99 %)
21 diff
(97.8 %id)
BM556304 duodenal adenocarcinoma, cell line, small intestine .c 157 to 1103 1 to 958       958/1034
(92 %)
23 diff
(97.8 %id)
BU543954 carcinoma, cell line, Prostate .c 159 to 1048 1 to 897       895/904
(99 %)
8 diff
(99.2 %id)
BT007432   .c 161 to 1178 1 to 1018       1018/1020
(99 %)
1 diff
(100.0 %id)
BM473989 leiomyosarcoma, uterus .c 168 to 1067 1 to 905       905/964
(93 %)
19 diff
(98.1 %id)
BQ717353 sympathetic trunk .c 169 to 1047 1 to 884       884/890
(99 %)
16 diff
(98.3 %id)
BM697645 eye, fetal eyes .c 169 to 682 1 to 514       514/514
(100 %)
1 diff
(99.9 %id)
BQ691220 ductal carcinoma, cell line, Pancreas .c 171 to 1047 1 to 884       884/885
(99 %)
14 diff
(98.5 %id)
CR985382 T-Lymphocytes .c 182 to 1120 1 to 940       940/941
(99 %)
2 diff
(99.8 %id)
BU173582 melanotic melanoma, cell line, skin .c 186 to 1049 1 to 867       867/906
(95 %)
11 diff
(98.8 %id)
BU157255 melanotic melanoma, cell line, skin .c 186 to 1067 1 to 895       895/904
(99 %)
21 diff
(97.7 %id)
BU196630 melanotic melanoma, cell line, skin .c 186 to 1089 1 to 911       911/930
(97 %)
14 diff
(98.5 %id)
BG681523 skin, squamous cell carcinoma .c 211 to 1116 1 to 913       911/940
(96 %)
12 diff
(98.8 %id)
BM553079 amelanotic melanoma, cell line, skin .c 235 to 1287 1 to 1067       1067/1088
(98 %)
39 diff
(96.5 %id)
BM808929 amelanotic melanoma, cell line, skin .c 236 to 1275 1 to 1059       1059/1060
(99 %)
39 diff
(96.4 %id)
BQ923154 eye, normal pigmented retinal epithelium .c 254 to 1099 1 to 854       854/924
(92 %)
20 diff
(97.9 %id)
BG677395 skin, squamous cell carcinoma .c 262 to 1142 1 to 883       883/883
(100 %)
5 diff
(99.5 %id)
CR997671 T-Lymphocytes .c 266 to 1146 1 to 881       881/881
(100 %)
0 diff
(100 %id)
BM697782 eye, fetal eyes .c 298 to 664 1 to 367       367/367
(100 %)
0 diff
(100 %id)
BQ433002 epithelioid carcinoma, Pancreas .c 315 to 1196 1 to 884       884/884
(100 %)
6 diff
(99.4 %id)
BG677628 skin, squamous cell carcinoma .c 319 to 1218 1 to 901       901/935
(96 %)
25 diff
(97.4 %id)
BQ435956 epithelioid carcinoma, Pancreas .c 322 to 1201 1 to 885       885/888
(99 %)
12 diff
(98.7 %id)
BQ957134 carcinoma, cell line, Prostate .c 324 to 1241 1 to 919       919/920
(99 %)
10 diff
(99.0 %id)
BQ717924 sympathetic trunk .c 336 to 1188 1 to 856       856/856
(100 %)
3 diff
(99.7 %id)
BG285522 bladder, transitional cell papilloma, cell line .c 339 to 1127 1 to 796       796/1098
(72 %)
15 diff
(98.7 %id)
BQ722737 dorsal root ganglia .c 366 to 1253 1 to 898       898/902
(99 %)
13 diff
(98.6 %id)
BU541302 carcinoma, cell line, Prostate .c 370 to 1250 1 to 892       892/916
(97 %)
13 diff
(98.6 %id)
TI_57230181   .c 397 to 1228 91 to 931       841/841
(100 %)
21 diff
(97.6 %id)
BU186489 large cell carcinoma, lung .c 398 to 1270 1 to 889       889/892
(99 %)
18 diff
(98.0 %id)
BG676021 skin, squamous cell carcinoma .c 414 to 1306 1 to 907       907/908
(99 %)
17 diff
(98.2 %id)
BQ937235 carcinoma, cell line, Prostate .c 416 to 1288 1 to 877       877/877
(100 %)
8 diff
(99.1 %id)
BG680563 skin, squamous cell carcinoma .c 438 to 1357 1 to 919       919/921
(99 %)
11 diff
(98.9 %id)
BM705796 eye, lens .c 444 to 940 1 to 497       497/498
(99 %)
3 diff
(99.4 %id)
BQ434550 leiomyosarcoma, uterus .c 453 to 1324 1 to 874       874/874
(100 %)
2 diff
(99.8 %id)
BM721005 eye, fetal eye .c 469 to 1028 1 to 560   fully sequenced,   560/560
(100 %)
0 diff
(100 %id)
BQ946506 epidermoid carcinoma, cell line, lung .c 480 to 1356 1 to 890       890/941
(94 %)
27 diff
(97.2 %id)
BU902592 leiomyosarcoma, uterus .c 491 to 1345 1 to 863       863/934
(92 %)
17 diff
(98.2 %id)
TI_149295795   .c 511 to 1473 1033 to 88   AAA   948/973
(97 %)
44 diff
(95.5 %id)
TI_154061016   .c 513 to 1473 1034 to 91   AAA   943/1031
(91 %)
27 diff
(97.4 %id)
TI_154034199   .c 518 to 1475 1041 to 84   AAA   958/973
(98 %)
16 diff
(98.4 %id)
BQ689281 ductal carcinoma, cell line, Pancreas .c 549 to 1401 1 to 858       858/953
(90 %)
7 diff
(99.3 %id)
TI_154128363   .c 560 to 1473 996 to 96   AAA   859/992
(86 %)
29 diff
(97.1 %id)
TI_154046473   .c 561 to 1475 995 to 88   AAA   908/1025
(88 %)
11 diff
(99.0 %id)
TI_154061278   .c 561 to 1473 983 to 80   AAA   904/1027
(88 %)
16 diff
(98.5 %id)
TI_154126485   .c 561 to 1473 971 to 64   AAA   909/1004
(90 %)
16 diff
(98.5 %id)
TI_154102192   .c 600 to 1473 946 to 84   AAA   863/943
(91 %)
60 diff
(93.7 %id)
TI_154123497   .c 602 to 1473 948 to 87   AAA   862/975
(88 %)
29 diff
(97.1 %id)
TI_149296068   .c 603 to 1473 946 to 85   AAA   862/967
(89 %)
17 diff
(98.3 %id)
TI_149298651   .c 603 to 1473 948 to 87   AAA   862/955
(90 %)
15 diff
(98.5 %id)
TI_154035402   .c 603 to 1473 959 to 97   AAA   863/947
(91 %)
13 diff
(98.7 %id)
TI_154110725   .c 603 to 1473 942 to 79   AAA   864/946
(91 %)
13 diff
(98.7 %id)
TI_154126075   .c 603 to 1473 943 to 83   AAA   861/943
(91 %)
30 diff
(96.9 %id)
TI_154128820   .c 603 to 1475 958 to 94   AAA   863/944
(91 %)
20 diff
(97.9 %id)
BQ931045 large cell carcinoma, lung .c 606 to 1473 916 to 44   AAA Submitted on the opposite strand 873/874
(99 %)
30 diff
(96.6 %id)
TI_154126033   .c 606 to 1473 941 to 78   AAA   864/988
(87 %)
23 diff
(97.7 %id)
BM916409 amelanotic melanoma, cell line, skin .c 607 to 1473 915 to 43   AAA Submitted on the opposite strand 873/1050
(83 %)
13 diff
(98.8 %id)
TI_154126385   .c 608 to 1473 929 to 73   AAA   861/965
(89 %)
26 diff
(97.4 %id)
TI_149287599   .c 609 to 1473 943 to 81   AAA   863/1146
(75 %)
15 diff
(98.7 %id)
TI_154034215   .c 609 to 1473 946 to 84   AAA   863/959
(89 %)
6 diff
(99.4 %id)
TI_154097448   .c 609 to 1473 945 to 83   AAA   863/1116
(77 %)
13 diff
(98.9 %id)
TI_154124744   .c 609 to 1473 924 to 63   AAA   862/963
(89 %)
15 diff
(98.5 %id)
TI_154128862   .c 609 to 1483 952 to 87   AAA   866/983
(88 %)
20 diff
(98.0 %id)
TI_154115316   .c 610 to 1473 948 to 93   AAA   800/1024
(78 %)
14 diff
(98.7 %id)
TI_154062356   .c 615 to 1473 911 to 60   AAA   852/922
(92 %)
12 diff
(98.7 %id)
TI_154115320   .c 615 to 1473 942 to 90   AAA   853/950
(89 %)
11 diff
(98.9 %id)
TI_154110707   .c 617 to 1473 951 to 101   AAA   851/939
(90 %)
17 diff
(98.2 %id)
TI_154102972   .c 637 to 1475 919 to 89   AAA   831/949
(87 %)
36 diff
(96.3 %id)
TI_154127675   .c 637 to 1473 917 to 89   AAA   829/995
(83 %)
11 diff
(98.9 %id)
TI_149315487   .c 640 to 1473 915 to 85   AAA   831/979
(84 %)
11 diff
(98.9 %id)
TI_154107130   .c 640 to 1473 914 to 86   AAA   829/946
(87 %)
9 diff
(99.1 %id)
TI_154060874   .c 677 to 1475 900 to 101   AAA   800/950
(84 %)
8 diff
(99.2 %id)
TI_154101744   .c 677 to 1473 863 to 66   AAA   798/926
(86 %)
7 diff
(99.3 %id)
TI_154102836   .c 677 to 1473 835 to 38   AAA   798/984
(81 %)
7 diff
(99.3 %id)
BQ921799 epidermoid carcinoma, cell line, lung .c 679 to 1473 816 to 19   AAA Submitted on the opposite strand 798/798
(100 %)
3 diff
(99.7 %id)
TI_149296951   .c 680 to 1473 877 to 85   AAA   793/942
(84 %)
3 diff
(99.7 %id)
TI_154101825   .c 680 to 1473 856 to 63   AAA   794/925
(85 %)
8 diff
(99.2 %id)
TI_154127379   .c 680 to 1475 867 to 78   AAA   790/985
(80 %)
26 diff
(97.4 %id)
TI_154130891   .c 680 to 1475 880 to 86   AAA   795/993
(80 %)
18 diff
(98.2 %id)
TI_154059492   .c 682 to 1473 851 to 65   AAA   787/977
(80 %)
16 diff
(98.4 %id)
TI_154126239   .c 683 to 1473 874 to 87   AAA   788/935
(84 %)
19 diff
(98.0 %id)
TI_149296611   .c 684 to 1473 870 to 82   AAA   789/966
(81 %)
10 diff
(99.0 %id)
TI_154090854   .c 684 to 1473 865 to 81   AAA   785/913
(85 %)
11 diff
(98.8 %id)
TI_154101380   .c 684 to 1479 855 to 61   AAA   795/797
(99 %)
5 diff
(99.4 %id)
TI_154101451   .c 684 to 1473 848 to 62   AAA   787/799
(98 %)
13 diff
(98.4 %id)
TI_154115479   .c 684 to 1473 868 to 84   AAA   785/963
(81 %)
14 diff
(98.6 %id)
TI_154131765   .c 684 to 1479 922 to 128   AAA   795/973
(81 %)
6 diff
(99.4 %id)
TI_154060968   .c 686 to 1473 890 to 110   AAA   781/1033
(75 %)
13 diff
(98.8 %id)
TI_149297680   .c 687 to 1473 844 to 59   AAA   786/969
(81 %)
6 diff
(99.4 %id)
TI_154059651   .c 687 to 1473 870 to 87   AAA   784/981
(79 %)
10 diff
(99.0 %id)
TI_154062140   .c 687 to 1473 884 to 101   AAA   784/995
(78 %)
6 diff
(99.4 %id)
TI_154125062   .c 687 to 1473 886 to 111   AAA   776/940
(82 %)
20 diff
(97.9 %id)
TI_154125099   .c 687 to 1473 871 to 99   AAA   773/936
(82 %)
20 diff
(97.9 %id)
TI_154127067   .c 687 to 1473 862 to 78   AAA   785/976
(80 %)
9 diff
(99.1 %id)
TI_154127310   .c 687 to 1473 875 to 91   AAA   785/977
(80 %)
6 diff
(99.4 %id)
TI_154102170   .c 688 to 1473 865 to 81   AAA   785/943
(83 %)
5 diff
(99.5 %id)
TI_154101515   .c 689 to 1473 866 to 82   AAA   785/809
(97 %)
7 diff
(99.2 %id)
TI_154100796   .c 690 to 1483 869 to 84   AAA   786/824
(95 %)
19 diff
(97.7 %id)
TI_154101427   .c 697 to 1483 876 to 91   AAA   786/787
(99 %)
7 diff
(99.2 %id)
TI_154130834   .c 697 to 1473 859 to 85   AAA   775/947
(81 %)
11 diff
(98.9 %id)
TI_154007398   .c 720 to 1475 849 to 95   AAA   755/959
(78 %)
4 diff
(99.6 %id)
CA310057 Bone, Enchondroma cell line .c 737 to 1479 761 to 19   AAA   743/743
(100 %)
0 diff
(100 %id)
TI_149295495   .c 748 to 1473 813 to 91   AAA   723/922
(78 %)
12 diff
(98.7 %id)
TI_149296364   .c 748 to 1473 771 to 59   AAA   713/917
(77 %)
16 diff
(98.3 %id)
TI_149299194   .c 748 to 1479 810 to 86   AAA   725/775
(93 %)
12 diff
(98.5 %id)
TI_149303852   .c 748 to 1473 805 to 85   AAA   721/925
(77 %)
5 diff
(99.5 %id)
TI_154046451   .c 748 to 1473 816 to 97   AAA   720/930
(77 %)
6 diff
(99.4 %id)
TI_154050162   .c 748 to 1479 822 to 95   AAA   728/962
(75 %)
10 diff
(99.0 %id)
TI_154125197   .c 748 to 1483 814 to 84   AAA   731/921
(79 %)
21 diff
(97.8 %id)
TI_154125896   .c 748 to 1483 801 to 70   AAA   732/971
(75 %)
12 diff
(98.8 %id)
TI_154127038   .c 748 to 1473 820 to 101   AAA   720/904
(79 %)
6 diff
(99.4 %id)
TI_154127974   .c 748 to 1473 826 to 108   AAA   719/952
(75 %)
17 diff
(98.3 %id)
TI_154127027   .c 750 to 1483 833 to 99   AAA   731/953
(76 %)
10 diff
(99.0 %id)
TI_154126062   .c 753 to 1473 797 to 81   AAA   717/909
(78 %)
8 diff
(99.2 %id)
TI_154098422   .c 760 to 1473 797 to 85   AAA   713/713
(100 %)
3 diff
(99.6 %id)
TI_154098444   .c 762 to 1473 799 to 89   AAA   711/711
(100 %)
3 diff
(99.6 %id)
TI_149282716   .c 764 to 1473 763 to 54   AAA   710/710
(100 %)
1 diff
(99.9 %id)
TI_149277654   .c 768 to 1473 794 to 90   AAA   705/705
(100 %)
1 diff
(99.9 %id)
TI_149277636   .c 769 to 1475 797 to 93   AAA   701/705
(99 %)
8 diff
(98.9 %id)
TI_154057883   .c 775 to 1473 776 to 87   AAA   690/894
(77 %)
21 diff
(97.7 %id)
TI_149277659   .c 778 to 1473 787 to 97   AAA   691/691
(100 %)
5 diff
(99.3 %id)
TI_154100237   .c 779 to 1475 788 to 93   AAA   696/696
(100 %)
1 diff
(99.9 %id)
TI_154098434   .c 781 to 1475 778 to 85   AAA   694/695
(99 %)
4 diff
(99.5 %id)
CA424261 Bone, Enchondroma cell line .c 782 to 1479 716 to 19   AAA   698/698
(100 %)
0 diff
(100 %id)
TI_149306272   .c 785 to 1473 778 to 91   AAA   688/921
(74 %)
1 diff
(99.9 %id)
TI_154016517   .c 785 to 1473 770 to 87   AAA   684/954
(71 %)
7 diff
(99.3 %id)
TI_154100252   .c 788 to 1473 771 to 86   AAA   686/686
(100 %)
1 diff
(99.9 %id)
TI_149280495   .c 789 to 1473 762 to 79   AAA   684/684
(100 %)
1 diff
(99.9 %id)
TI_154046891   .c 796 to 1479 769 to 87   AAA   683/982
(69 %)
4 diff
(99.6 %id)
TI_154018486   .c 813 to 1473 744 to 84   AAA   661/724
(91 %)
2 diff
(99.8 %id)
AI888571 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .c 822 to 1473 671 to 19   AAA   653/653
(100 %)
5 diff
(99.3 %id)
AI608797 normal gingiva (cell line from immortalizedkeratinocytes) .c 841 to 1474 635 to 1       635/700
(90 %)
2 diff
(99.8 %id)
BQ020306 Chondrosarcoma, Left Pubic Bone .c 843 to 1473 648 to 19   AAA   630/630
(100 %)
0 diff
(100 %id)
BQ020329 Chondrosarcoma, Left Pubic Bone .c 843 to 1483 658 to 19   AAA   640/640
(100 %)
0 diff
(100 %id)
AI889512 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .c 845 to 1475 633 to 1       633/633
(100 %)
2 diff
(99.7 %id)
AA441982   .c 848 to 1097 1 to 250   fully sequenced,   250/250
(100 %)
0 diff
(100 %id)
BQ017700 Chondrosarcoma, Left Pubic Bone .c 848 to 1473 644 to 19   AAA   626/626
(100 %)
0 diff
(100 %id)
BM994992 Chondrosarcoma, Left Pubic Bone .c 848 to 1473 644 to 19   AAA   626/626
(100 %)
0 diff
(100 %id)
BQ020006 Chondrosarcoma, Left Pubic Bone .c 848 to 1473 644 to 19   AAA   626/626
(100 %)
1 diff
(99.9 %id)
BM992788 lung, Metastatic Chondrosarcoma .c 848 to 1473 644 to 19   AAA   626/626
(100 %)
2 diff
(99.7 %id)
BU684108 lung, Primary Lung Cystic Fibrosis EpithelialCells .c 848 to 1473 644 to 19   AAA   626/626
(100 %)
0 diff
(100 %id)
CA417749 Chondrosarcoma Cell line .c 848 to 1475 644 to 17   AAA   628/628
(100 %)
1 diff
(99.9 %id)
BU947700 insulinoma, Pancreas .c 849 to 1475 643 to 17   AAA   627/627
(100 %)
0 diff
(100 %id)
CA421922 Bone, Enchondroma cell line .c 849 to 1473 643 to 19   AAA   625/625
(100 %)
3 diff
(99.6 %id)
CA421161 Bone, Enchondroma cell line .c 849 to 1473 643 to 19   AAA   625/625
(100 %)
0 diff
(100 %id)
AW337134 adenocarcinoma, Pancreas .c 851 to 1473 638 to 15   AAA   624/624
(100 %)
2 diff
(99.7 %id)
BU074236.
matches multiple genes
insulinoma, Pancreas .c 854 to 1479 643 to 18   AAA also hits gene C22orf43 626/626
(100 %)
0 diff
(100 %id)
BQ019414 Chondrosarcoma, Left Pubic Bone .c 859 to 1475 633 to 17   AAA   617/625
(98 %)
0 diff
(100 %id)
TI_149279275   .c 859 to 1473 695 to 81   AAA   615/703
(87 %)
0 diff
(100 %id)
BM969471 lung, Primary Lung Epithelial Cells .c 859 to 1473 633 to 19   AAA   615/627
(98 %)
0 diff
(100 %id)
AA155801.
matches multiple genes
  .c 860 to 1466 596 to 1     also hits gene ANXA2P2 600/603
(99 %)
12 diff
(98.1 %id)
BG110275 Bone, osteosarcoma, cell line .c 861 to 1473 1 to 612   AAA   612/612
(100 %)
1 diff
(99.9 %id)
CF130493 Chondrosarcoma Lung Metastasis cell lines, lung .c 864 to 1480 1 to 617       617/643
(95 %)
1 diff
(99.9 %id)
BM995271 Chondrosarcoma, Left Pubic Bone .c 865 to 1473 626 to 19   AAA   608/608
(100 %)
3 diff
(99.6 %id)
BQ020519 Fibrosarcoma .c 865 to 1483 637 to 19   AAA   619/619
(100 %)
0 diff
(100 %id)
CA434939 lung, Metastatic Chondrosarcoma .c 865 to 1475 627 to 17   AAA   611/611
(100 %)
0 diff
(100 %id)
BM994953 Chondrosarcoma, Left Pubic Bone .c 868 to 1475 624 to 17   AAA   608/608
(100 %)
0 diff
(100 %id)
AA594983 Prostate, prostate tumor .c 869 to 1472 604 to 1       604/604
(100 %)
0 diff
(100 %id)
CA435965 lung, Metastatic Chondrosarcoma .c 873 to 1483 629 to 19   AAA   611/611
(100 %)
0 diff
(100 %id)
CN480954 eye .c 877 to 1473 623 to 27   AAA   597/597
(100 %)
0 diff
(100 %id)
BM997639 lung, Metastatic Chondrosarcoma .c 877 to 1473 615 to 19   AAA   597/598
(99 %)
3 diff
(99.5 %id)
TI_149280764   .c 877 to 1473 677 to 81   AAA   597/815
(73 %)
0 diff
(100 %id)
BM508068 insulinoma, Pancreas .c 878 to 1473 611 to 16   AAA   596/596
(100 %)
0 diff
(100 %id)
CV575437 cornea, eye .c 879 to 1473 617 to 23   AAA Submitted on the opposite strand 595/595
(100 %)
0 diff
(100 %id)
BM969933 lung, Primary Lung Epithelial Cells .c 883 to 1473 609 to 19   AAA   591/591
(100 %)
0 diff
(100 %id)
CA420581 Bone, Enchondroma cell line .c 883 to 1473 609 to 19   AAA   591/605
(97 %)
0 diff
(100 %id)
CA441890 Chondrosarcoma, Left Pubic Bone .c 884 to 1483 618 to 19   AAA   600/600
(100 %)
0 diff
(100 %id)
BM272557 insulinoma, Pancreas .c 887 to 1473 603 to 17   AAA   587/587
(100 %)
0 diff
(100 %id)
BQ019941 Chondrosarcoma, Left Pubic Bone .c 887 to 1475 605 to 17   AAA   589/589
(100 %)
0 diff
(100 %id)
CA416294 Chondrosarcoma Cell line .c 887 to 1473 605 to 19   AAA   587/587
(100 %)
0 diff
(100 %id)
BU730153.
matches multiple genes
eye, Retina Foveal and Macular .c 898 to 1473 594 to 19   AAA also hits gene ANXA2P1 576/582
(98 %)
1 diff
(99.9 %id)
CA416110 Chondrosarcoma Cell line .c 902 to 1483 600 to 19   AAA   582/582
(100 %)
0 diff
(100 %id)
AA100163 colon, tumor .c 917 to 1228 1 to 312   fully sequenced,   312/312
(100 %)
0 diff
(100 %id)
BU736070 eye, fetal eyes .c 918 to 1473 574 to 19   AAA   556/556
(100 %)
0 diff
(100 %id)
BM991327 lung, Lung Focal Fibrosis .c 940 to 1674 748 to 19   tiling clone, AAA   730/731
(99 %)
5 diff
(99.4 %id)
BM678626 eye, fetal eye .c 967 to 1473 525 to 19   fully sequenced, AAA   507/507
(100 %)
0 diff
(100 %id)
BU734992 eye, lens .c 1015 to 1473 477 to 19   AAA   459/459
(100 %)
0 diff
(100 %id)
BM695271 eye, optic nerve .c 1027 to 1477 1 to 451   fully sequenced,   451/451
(100 %)
2 diff
(99.6 %id)
AA441983   .c 1067 to 1480 417 to 4   fully sequenced,   414/417
(99 %)
0 diff
(100 %id)
BM666434 eye, optic nerve .c 1141 to 1475 353 to 19   fully sequenced, AAA   335/335
(100 %)
0 diff
(100 %id)
AA100102 colon, tumor .c 1198 to 1476 280 to 1   fully sequenced,   280/280
(100 %)
1 diff
(99.7 %id)
BU735834 eye, fetal eyes .c 1259 to 1475 233 to 17   AAA   217/217
(100 %)
0 diff
(100 %id)
BC023990 Bladder, carcinoma .d 1 to 1446 5 to 1450 V293A tiling clone, available from MGC, AAA   1446/1446
(100 %)
2 diff
(99.9 %id)
CB139776 Liver .d 1 to 256 1 to 257       257/257
(100 %)
2 diff
(99.3 %id)
NM_001002857.1   .d 1 to 1634 1 to 1634 exact RefSeq, AAA   1634/1634
(100 %)
0 diff
(100 %id)
AU138581 placenta .d 2 to 663 2 to 664   capped   663/668
(99 %)
5 diff
(99.3 %id)
BX425113 placenta .d 9 to 881 1 to 872   fully sequenced,   872/872
(100 %)
2 diff
(99.8 %id)
CR599823 placenta .d 9 to 1435 1 to 1427 exact     1427/1427
(100 %)
0 diff
(100 %id)
AU116993 whole embryo, mainly head .d 9 to 725 2 to 723   capped   722/736
(98 %)
10 diff
(98.7 %id)
CR616100 T cells (Jurkat cell line) Cot10-normalized .d 11 to 1421 1 to 1411 exact     1411/1411
(100 %)
0 diff
(100 %id)
AL558111 T cells from T cell leukemia .d 11 to 755 1 to 745   fully sequenced,   745/745
(100 %)
0 diff
(100 %id)
BC001388 Colon, adenocarcinoma .d 13 to 1449 1 to 1437 exact available from MGC, AAA   1437/1437
(100 %)
0 diff
(100 %id)
BE730350 melanotic melanoma, skin .d 13 to 812 32 to 824       793/1010
(78 %)
21 diff
(98.0 %id)
BG766646 melanotic melanoma, high MDR (cell line), skin .d 13 to 864 1 to 853       853/854
(99 %)
12 diff
(98.6 %id)
BG753414 eye, normal pigmented retinal epithelium .d 13 to 834 1 to 825       825/825
(100 %)
7 diff
(99.2 %id)
BQ880803 epidermoid carcinoma, cell line, salivary gland .d 13 to 854 1 to 849       847/902
(93 %)
19 diff
(97.9 %id)
CB120565 Liver .d 14 to 279 1 to 266       266/266
(100 %)
1 diff
(99.7 %id)
CN407809 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .d 15 to 764 1 to 750       750/750
(100 %)
3 diff
(99.6 %id)
CR596938 Placenta Cot 25-normalized .d 15 to 1426 1 to 1412 exact     1412/1412
(100 %)
0 diff
(100 %id)
AL547110 placenta, Placenta Cot 25-normalized .d 15 to 695 1 to 687   fully sequenced,   687/687
(100 %)
10 diff
(98.6 %id)
BG250328 adenocarcinoma, cell line, Liver .d 15 to 670 1 to 651       651/955
(68 %)
15 diff
(98.5 %id)
BU541179 carcinoma, cell line, Prostate .d 15 to 914 1 to 904       904/904
(100 %)
6 diff
(99.4 %id)
BM043082 carcinoma, cell line, Prostate .d 16 to 833 1 to 816       816/817
(99 %)
12 diff
(98.6 %id)
BQ431837 melanotic melanoma, skin .d 16 to 883 1 to 876       876/876
(100 %)
8 diff
(99.1 %id)
CN407778 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .d 17 to 664 1 to 647       647/647
(100 %)
1 diff
(99.9 %id)
BG252268 adenocarcinoma, cell line, Liver .d 17 to 712 13 to 710       698/710
(98 %)
10 diff
(98.6 %id)
BQ947620 carcinoma, cell line, Prostate .d 17 to 916 1 to 907       907/929
(97 %)
16 diff
(98.3 %id)
BU552408 carcinoma, cell line, Prostate .d 17 to 920 1 to 909       909/910
(99 %)
9 diff
(99.1 %id)
BG122728 adenocarcinoma, cell line, Liver .d 18 to 725 1 to 703       704/1004
(70 %)
18 diff
(98.3 %id)
BG250435 adenocarcinoma, cell line, Liver .d 18 to 667 11 to 660       650/931
(69 %)
10 diff
(99.0 %id)
BG253623 adenocarcinoma, cell line, Liver .d 18 to 724 1 to 705       705/942
(74 %)
7 diff
(99.3 %id)
BU172776 melanotic melanoma, skin .d 18 to 902 1 to 887       887/887
(100 %)
4 diff
(99.6 %id)
TI_57229799   .d 18 to 833 89 to 905       817/817
(100 %)
7 diff
(99.2 %id)
CN407918 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .d 19 to 775 1 to 759       759/759
(100 %)
6 diff
(99.3 %id)
BG419131 Kidney, renal cell adenocarcinoma .d 19 to 720 1 to 705       705/959
(73 %)
12 diff
(98.8 %id)
BI821694 pooled brain, lung, testis .d 19 to 772 1 to 764       764/783
(97 %)
29 diff
(96.3 %id)
BU542695 carcinoma, cell line, Prostate .d 19 to 886 1 to 875       875/875
(100 %)
11 diff
(98.8 %id)
AA370508 Prostate .d 20 to 299 1 to 280       280/280
(100 %)
0 diff
(100 %id)
BE380100 bladder, carcinoma, cell line .d 20 to 662 1 to 643       643/847
(75 %)
11 diff
(98.8 %id)
BF684538 leiomyosarcoma cell line, uterus .d 20 to 733 1 to 720       720/893
(80 %)
21 diff
(97.7 %id)
BG282280 melanotic melanoma, skin .d 20 to 711 1 to 693       693/698
(99 %)
10 diff
(98.6 %id)
BG475668 melanotic melanoma, skin .d 20 to 770 1 to 757       755/757
(99 %)
14 diff
(98.2 %id)
BG747624 eye, normal pigmented retinal epithelium .d 20 to 577 1 to 558       558/558
(100 %)
2 diff
(99.7 %id)
BG746763 adenocarcinoma cell line, colon .d 20 to 848 1 to 833       833/837
(99 %)
9 diff
(99.0 %id)
BI084120 epidermoid carcinoma, cell line, salivary gland .d 20 to 709 1 to 691   fully sequenced,   691/691
(100 %)
5 diff
(99.3 %id)
BI870523 adenocarcinoma, cell line, Liver .d 20 to 833 1 to 815       815/815
(100 %)
7 diff
(99.2 %id)
BM006585 ductal carcinoma, cell line, Pancreas .d 20 to 807 1 to 790       790/791
(99 %)
9 diff
(98.9 %id)
BM047634 carcinoma, cell line, Prostate .d 20 to 733 1 to 718       718/1012
(70 %)
12 diff
(98.9 %id)
BU180386 ductal carcinoma, cell line, Pancreas .d 20 to 897 1 to 884       884/960
(92 %)
12 diff
(98.8 %id)
TI_57236887   .d 20 to 805 72 to 857       786/857
(91 %)
16 diff
(98.2 %id)
AA370717 Prostate .d 21 to 280 1 to 260       260/260
(100 %)
0 diff
(100 %id)
BE739001 hypernephroma, Kidney .d 21 to 668 1 to 641       641/884
(72 %)
22 diff
(97.6 %id)
BE866636 bladder, carcinoma, cell line .d 21 to 725 1 to 699       700/727
(96 %)
26 diff
(96.5 %id)
BF688207 eye, normal pigmented retinal epithelium .d 21 to 666 1 to 646       646/968
(66 %)
7 diff
(99.3 %id)
BG330651 large cell carcinoma, lung .d 21 to 789 1 to 762       762/903
(84 %)
20 diff
(97.8 %id)
BG330316 large cell carcinoma, lung .d 21 to 777 1 to 756       756/785
(96 %)
17 diff
(97.9 %id)
BG752657 eye, normal pigmented retinal epithelium .d 21 to 841 1 to 831       831/831
(100 %)
19 diff
(97.8 %id)
BI910964 leukocyte .d 21 to 805 1 to 786       786/786
(100 %)
13 diff
(98.4 %id)
BM554381 amelanotic melanoma, cell line, skin .d 21 to 981 27 to 983       958/1141
(83 %)
18 diff
(98.5 %id)
BQ687869 ductal carcinoma, cell line, Pancreas .d 21 to 907 1 to 887       887/892
(99 %)
8 diff
(99.2 %id)
DR156872 human embryonic stem cells differentiated toan early endodermal cell type .d 21 to 818 1 to 798       798/798
(100 %)
0 diff
(100 %id)
TI_59395697   .d 21 to 807 63 to 851       789/790
(99 %)
8 diff
(99.0 %id)
BM048118 carcinoma, cell line, Prostate .d 22 to 753 1 to 735       735/735
(100 %)
5 diff
(99.4 %id)
CA488443   .d 22 to 903 1 to 896       896/1007
(88 %)
13 diff
(98.8 %id)
CB118748 Liver .d 22 to 650 1 to 629       629/629
(100 %)
0 diff
(100 %id)
BE891378 melanotic melanoma, skin .d 23 to 658 1 to 636       636/636
(100 %)
0 diff
(100 %id)
BG119966 adenocarcinoma, cell line, Liver .d 23 to 725 1 to 710       708/845
(83 %)
11 diff
(98.7 %id)
BG746730 adenocarcinoma cell line, colon .d 23 to 885 1 to 866       866/873
(99 %)
16 diff
(98.2 %id)
BM810774 amelanotic melanoma, cell line, skin .d 23 to 725 1 to 705       705/1095
(64 %)
9 diff
(99.2 %id)
BU196002 melanotic melanoma, cell line, skin .d 23 to 869 1 to 849       849/849
(100 %)
5 diff
(99.5 %id)
BU185855 ductal carcinoma, cell line, Pancreas .d 23 to 863 1 to 844       844/934
(90 %)
21 diff
(97.8 %id)
BU174851 ductal carcinoma, cell line, Pancreas .d 23 to 916 1 to 896       896/899
(99 %)
10 diff
(98.9 %id)
BU174466 ductal carcinoma, cell line, Pancreas .d 23 to 903 1 to 891       891/902
(98 %)
22 diff
(97.6 %id)
BU163835 epidermoid carcinoma, cell line, salivary gland .d 23 to 894 1 to 877       877/877
(100 %)
8 diff
(99.1 %id)
BU186116 epidermoid carcinoma, cell line, salivary gland .d 23 to 903 1 to 886       884/888
(99 %)
15 diff
(98.4 %id)
BQ692023 ductal carcinoma, cell line, Pancreas .d 23 to 717 1 to 699       697/881
(79 %)
8 diff
(99.1 %id)
BQ671069 epidermoid carcinoma, cell line, salivary gland .d 23 to 896 1 to 875       875/875
(100 %)
5 diff
(99.5 %id)
BQ686031 ductal carcinoma, cell line, Pancreas .d 23 to 881 1 to 866       866/869
(99 %)
10 diff
(98.9 %id)
BQ672313 epidermoid carcinoma, cell line, salivary gland .d 23 to 914 1 to 897       897/920
(97 %)
26 diff
(97.2 %id)
BQ670580 epidermoid carcinoma, cell line, salivary gland .d 23 to 916 1 to 898       898/904
(99 %)
17 diff
(98.2 %id)
BU502545 carcinoma, cell line, Prostate .d 23 to 790 1 to 773       773/936
(82 %)
6 diff
(99.4 %id)
BQ939564 carcinoma, cell line, Prostate .d 23 to 915 1 to 903       903/908
(99 %)
30 diff
(96.7 %id)
BG323393 Kidney, renal cell adenocarcinoma .d 24 to 775 1 to 747       747/756
(98 %)
19 diff
(97.5 %id)
CD243066 brain, Pituitary .d 24 to 664 1 to 642       642/927
(69 %)
4 diff
(99.6 %id)
CB145740 Liver .d 24 to 270 1 to 247       247/247
(100 %)
0 diff
(100 %id)
DA135613 alzheimer cortex .d 25 to 565 2 to 542   capped   541/541
(100 %)
2 diff
(99.7 %id)
BQ957655 carcinoma, cell line, Prostate .d 25 to 958 1 to 932       932/935
(99 %)
18 diff
(98.1 %id)
CN407829 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .d 28 to 351 1 to 324       324/324
(100 %)
0 diff
(100 %id)
ES314766 occipital scalp hair, skin .d 30 to 177 1 to 148       148/148
(100 %)
4 diff
(97.3 %id)
BE271547 adenocarcinoma cell line, ovary .d 30 to 656 1 to 626       626/627
(99 %)
7 diff
(98.9 %id)
BE304858 adenocarcinoma cell line, colon .d 32 to 513 1 to 482       482/482
(100 %)
0 diff
(100 %id)
BE546069 cervical carcinoma cell line, cervix .d 33 to 752 1 to 720       720/894
(80 %)
23 diff
(97.5 %id)
BE734341 choriocarcinoma, placenta .d 33 to 699 1 to 665       665/665
(100 %)
7 diff
(99.0 %id)
BE904383 epithelioid carcinoma, Pancreas .d 33 to 638 1 to 608       608/847
(71 %)
12 diff
(98.6 %id)
CB120164 Liver .d 33 to 191 1 to 159       159/161
(98 %)
7 diff
(95.7 %id)
BE304826 adenocarcinoma cell line, colon .d 34 to 662 3 to 632       630/684
(92 %)
13 diff
(98.1 %id)
BE732156 choriocarcinoma, placenta .d 34 to 747 1 to 710       710/711
(99 %)
14 diff
(98.1 %id)
AA307450 colon .d 35 to 446 1 to 412       412/412
(100 %)
1 diff
(99.8 %id)
BE276861 melanotic melanoma, skin .d 35 to 591 1 to 557       557/557
(100 %)
6 diff
(99.0 %id)
BE393737 endometrium, adenocarcinoma cell line, uterus .d 35 to 725 1 to 690       690/727
(94 %)
20 diff
(97.3 %id)
BE901767 choriocarcinoma, placenta .d 35 to 820 1 to 776       776/983
(78 %)
25 diff
(97.5 %id)
BE278051 choriocarcinoma, placenta .d 40 to 640 1 to 601       601/601
(100 %)
0 diff
(100 %id)
BE901729 choriocarcinoma, placenta .d 40 to 725 1 to 686       686/953
(71 %)
8 diff
(99.2 %id)
AA704136 bone marrow stroma .d 41 to 665 1 to 625     Submitted on the opposite strand 625/789
(79 %)
6 diff
(99.3 %id)
BE514628 adenocarcinoma cell line, ovary .d 41 to 726 1 to 680       680/719
(94 %)
10 diff
(98.7 %id)
BE906711 epithelioid carcinoma, Pancreas .d 41 to 780 1 to 742       740/814
(90 %)
7 diff
(99.2 %id)
BE746908 adenocarcinoma cell line, ovary .d 41 to 703 1 to 661       661/661
(100 %)
3 diff
(99.6 %id)
BE741699 adenocarcinoma cell line, ovary .d 41 to 775 1 to 728       728/936
(77 %)
16 diff
(98.3 %id)
BG281694 melanotic melanoma, skin .d 43 to 705 22 to 690       669/1020
(65 %)
15 diff
(98.6 %id)
BY996971   .d 44 to 667 9 to 632       624/632
(98 %)
6 diff
(99.1 %id)
BG122100 adenocarcinoma, cell line, Liver .d 52 to 725 1 to 666       666/667
(99 %)
9 diff
(98.7 %id)
BM042991 carcinoma, cell line, Prostate .d 52 to 795 1 to 748       748/861
(86 %)
20 diff
(97.7 %id)
CB123563 Liver .d 57 to 657 1 to 601       601/601
(100 %)
0 diff
(100 %id)
CN407841 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .d 62 to 708 1 to 646       646/646
(100 %)
2 diff
(99.7 %id)
BE745433 adenocarcinoma cell line, ovary .d 62 to 768 1 to 708       708/708
(100 %)
6 diff
(99.2 %id)
CN407795 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .d 65 to 598 1 to 533       533/533
(100 %)
1 diff
(99.9 %id)
BM763246 myeloma .d 65 to 734 1 to 670       670/670
(100 %)
0 diff
(100 %id)
TI_154188058   .d 68 to 879 123 to 924       802/905
(88 %)
14 diff
(98.5 %id)
AA370772 Prostate .d 72 to 320 1 to 249       249/249
(100 %)
0 diff
(100 %id)
CN407813 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .d 89 to 550 1 to 462       462/462
(100 %)
1 diff
(99.8 %id)
BM925223 pooled lung and spleen .d 92 to 980 1 to 891       891/1039
(85 %)
17 diff
(98.4 %id)
CB149167 Liver .d 109 to 338 1 to 230       230/230
(100 %)
1 diff
(99.6 %id)
AL572191 placenta, Placenta Cot 25-normalized .d 634 to 1424 796 to 4   fully sequenced,   793/796
(99 %)
1 diff
(99.9 %id)
BE379669 bladder, carcinoma, cell line .d 664 to 1387 747 to 10       735/797
(92 %)
24 diff
(97.0 %id)
BI084911 epidermoid carcinoma, cell line, salivary gland .d 679 to 1411 735 to 2   fully sequenced,   734/735
(99 %)
1 diff
(99.9 %id)
AL580020 T cells from T cell leukemia .d 694 to 1421 730 to 1   fully sequenced,   730/730
(100 %)
10 diff
(98.7 %id)
BF689142 eye, normal pigmented retinal epithelium .d 817 to 1595 812 to 33   tiling clone,   780/1210
(64 %)
9 diff
(99.3 %id)
BX433620 placenta .d 851 to 1435 586 to 1   fully sequenced,   586/586
(100 %)
10 diff
(98.3 %id)
AU143937 whole embryo, mainly head .d 914 to 1449 534 to 1       534/564
(94 %)
14 diff
(97.6 %id)
DB378436 placenta .d 914 to 1449 531 to 1       534/562
(95 %)
18 diff
(96.8 %id)
BQ432136 melanotic melanoma, skin .e 1 to 785 1 to 792   tiling clone,   792/803
(98 %)
12 diff
(98.6 %id)
DC380539 placenta .e 3 to 549 1 to 547       547/547
(100 %)
0 diff
(100 %id)
TI_57183411   .e 15 to 679 83 to 747       665/747
(89 %)
6 diff
(99.2 %id)
EY198476 intestinal (Lauren) gastric adenocarcinoma, stomach .e 51 to 485 3 to 437       435/437
(99 %)
7 diff
(98.4 %id)
EY198519 intestinal (Lauren) gastric adenocarcinoma, stomach .e 53 to 478 4 to 429       426/429
(99 %)
6 diff
(98.7 %id)
EY198534 intestinal (Lauren) gastric adenocarcinoma, stomach .e 53 to 450 4 to 397       394/398
(98 %)
16 diff
(96.0 %id)
TI_44344713   .e 53 to 828 85 to 859       775/859
(90 %)
8 diff
(99.1 %id)
FN059125 breast carcinoma .e 54 to 125 1 to 72       72/72
(100 %)
5 diff
(93.1 %id)
FN144985 breast carcinoma .e 54 to 138 1 to 87       87/87
(100 %)
7 diff
(92.0 %id)
CF595666 Stomach, adenocarcinoma .e 54 to 701 1 to 647       647/764
(84 %)
7 diff
(99.1 %id)
CX868492 embryonic stem .e 55 to 807 1 to 753       753/753
(100 %)
0 diff
(100 %id)
CF596617 ovary .e 55 to 794 1 to 744       744/747
(99 %)
15 diff
(98.0 %id)
CF597184 ovary .e 55 to 793 1 to 738       738/743
(99 %)
9 diff
(98.8 %id)
FN140948 breast carcinoma .e 56 to 125 1 to 71       71/71
(100 %)
6 diff
(91.6 %id)
BG571338 placenta .e 56 to 794 1 to 733       733/770
(95 %)
15 diff
(98.1 %id)
DC382732 placenta .e 56 to 602 1 to 547       547/547
(100 %)
0 diff
(100 %id)
FN174914 breast carcinoma .e 57 to 125 1 to 68       68/68
(100 %)
4 diff
(94.2 %id)
BF218741 brain, glioblastoma .e 57 to 563 1 to 520       491/870
(56 %)
58 diff
(93.4 %id)
CD707629 normal nasopharynx .e 58 to 143 22 to 109       88/109
(80 %)
6 diff
(94.5 %id)
CU455239 epidermis .e 58 to 563 25 to 530       506/530
(95 %)
8 diff
(98.5 %id)
BC066955 testis .e 58 to 1425 1 to 1368 exact available from MGC, AAA   1368/1368
(100 %)
1 diff
(100.0 %id)
TI_44166265   .e 58 to 685 90 to 715       626/715
(87 %)
7 diff
(99.1 %id)
NM_004039.2   .e 58 to 1610 1 to 1553 exact RefSeq, AAA   1553/1553
(100 %)
0 diff
(100 %id)
DC386735   .e 58 to 893 1 to 835       835/835
(100 %)
2 diff
(99.8 %id)
TI_154189669   .e 58 to 890 31 to 858       828/1055
(78 %)
11 diff
(99.0 %id)
AK222542 adipose tissue .e 59 to 1401 1 to 1343 L331P     1343/1343
(100 %)
1 diff
(100.0 %id)
DB293446   .e 59 to 864 2 to 810   capped   809/809
(100 %)
6 diff
(99.3 %id)
D00017 placenta .e 64 to 1425 1 to 1362 exact     1362/1362
(100 %)
0 diff
(100 %id)
CR622642 Placenta Cot 25-normalized .e 65 to 1390 1 to 1326 exact     1326/1326
(100 %)
0 diff
(100 %id)
BC013843.
matches multiple genes
melanotic melanoma, skin, Skin, melanotic melanoma. .e 65 to 1425 1 to 1361 exact available from MGC, AAA also hits gene PMP2 1361/1361
(100 %)
0 diff
(100 %id)
TI_57235286   .e 65 to 784 57 to 776       720/779
(92 %)
8 diff
(99.0 %id)
TI_59389746   .e 65 to 730 64 to 730       667/667
(100 %)
1 diff
(99.9 %id)
CR598583 T cells (Jurkat cell line) Cot10-normalized .e 66 to 1388 1 to 1323 exact     1323/1323
(100 %)
0 diff
(100 %id)
TI_59387151   .e 66 to 680 59 to 673       615/615
(100 %)
0 diff
(100 %id)
BX446532 placenta .e 67 to 1069 1 to 1002       1002/1002
(100 %)
10 diff
(99.1 %id)
CR620533 placenta .e 67 to 1403 1 to 1337 exact     1337/1337
(100 %)
0 diff
(100 %id)
BQ438784 epithelioid carcinoma, Pancreas .e 67 to 900 1 to 837       837/885
(94 %)
8 diff
(99.1 %id)
BQ217258 large cell carcinoma, lung .e 67 to 926 1 to 865       865/865
(100 %)
7 diff
(99.2 %id)
BQ722137 sympathetic trunk .e 67 to 946 1 to 885       885/898
(98 %)
7 diff
(99.3 %id)
BU541480 carcinoma, cell line, Prostate .e 67 to 948 1 to 884       884/896
(98 %)
7 diff
(99.3 %id)
BU543887 carcinoma, cell line, Prostate .e 67 to 955 1 to 894       894/907
(98 %)
10 diff
(98.9 %id)
DN602216 human embryonic stem cells .e 67 to 944 1 to 878       878/878
(100 %)
0 diff
(100 %id)
CR611402 Placenta Cot 25-normalized .e 68 to 1407 1 to 1340 exact     1340/1340
(100 %)
0 diff
(100 %id)
CR616357 Placenta Cot 25-normalized .e 68 to 1425 1 to 1358 exact     1358/1358
(100 %)
0 diff
(100 %id)
CR625736 placenta .e 68 to 1404 1 to 1337 exact     1337/1337
(100 %)
0 diff
(100 %id)
AL553268 placenta, Placenta Cot 25-normalized .e 68 to 671 1 to 604   fully sequenced,   604/604
(100 %)
0 diff
(100 %id)
ES310979 scalp interfollicular dermis, skin .e 68 to 478 1 to 411       411/411
(100 %)
3 diff
(99.3 %id)
BU166266 melanotic melanoma, skin .e 68 to 948 1 to 884       884/922
(95 %)
9 diff
(99.1 %id)
TI_57229896   .e 68 to 892 87 to 918       832/901
(92 %)
21 diff
(97.7 %id)
AL540332 placenta .e 69 to 731 1 to 663   fully sequenced,   663/663
(100 %)
2 diff
(99.7 %id)
BQ718701 sympathetic trunk .e 69 to 950 1 to 882       882/962
(91 %)
6 diff
(99.4 %id)
CR590378 placenta .e 70 to 1396 1 to 1327 exact     1327/1327
(100 %)
0 diff
(100 %id)
ES308348 beard hair, skin .e 70 to 226 1 to 157       157/157
(100 %)
0 diff
(100 %id)
ES308770 beard hair, skin .e 70 to 298 1 to 228       228/228
(100 %)
1 diff
(99.6 %id)
ES309980 scalp interfollicular dermis, skin .e 70 to 563 1 to 496       496/497
(99 %)
8 diff
(98.4 %id)
ES310807 scalp interfollicular dermis, skin .e 70 to 601 1 to 527       527/649
(81 %)
10 diff
(98.5 %id)
BG744002 blood, natural killer cells, cell line .e 70 to 671 1 to 602   fully sequenced,   602/602
(100 %)
0 diff
(100 %id)
BG763005 melanotic melanoma, high MDR (cell line), skin .e 70 to 960 1 to 890       890/985
(90 %)
16 diff
(98.4 %id)
BM462458 leiomyosarcoma, uterus .e 70 to 956 1 to 895       895/978
(91 %)
17 diff
(98.3 %id)
BM040937 Kidney, Wilms' tumor, cell line .e 70 to 775 1 to 708   fully sequenced,   708/708
(100 %)
3 diff
(99.6 %id)
BQ880890 dorsal root ganglia .e 70 to 915 1 to 858       854/864
(98 %)
15 diff
(98.3 %id)
CD517380 White Matter .e 70 to 900 1 to 833       833/906
(91 %)
6 diff
(99.4 %id)
TI_45133825   .e 70 to 830 40 to 794       755/795
(94 %)
13 diff
(98.4 %id)
TI_57187403   .e 70 to 900 52 to 877       826/868
(95 %)
12 diff
(98.7 %id)
TI_59395843   .e 70 to 750 60 to 741       682/682
(100 %)
4 diff
(99.5 %id)
TI_154194046   .e 70 to 900 49 to 879       831/1044
(79 %)
13 diff
(98.8 %id)
BC052567 Prostate, carcinoma .e 71 to 1425 1 to 1355 exact available from MGC, AAA   1355/1355
(100 %)
1 diff
(100.0 %id)
CR617962 Placenta Cot 25-normalized .e 71 to 1399 1 to 1329 exact     1329/1329
(100 %)
0 diff
(100 %id)
AL550075 placenta, Placenta Cot 25-normalized .e 71 to 671 1 to 601   fully sequenced,   601/601
(100 %)
0 diff
(100 %id)
ES307452 beard hair, skin .e 71 to 242 1 to 172       172/172
(100 %)
0 diff
(100 %id)
ES307962 beard hair, skin .e 71 to 325 1 to 255       255/255
(100 %)
2 diff
(99.3 %id)
ES309787 scalp interfollicular dermis, skin .e 71 to 542 1 to 471       471/471
(100 %)
7 diff
(98.6 %id)
BQ439768 melanotic melanoma, skin .e 71 to 929 1 to 865       865/869
(99 %)
11 diff
(98.8 %id)
TI_57239624   .e 71 to 862 99 to 894       796/899
(88 %)
20 diff
(97.8 %id)
CR998379 T-Lymphocytes .e 71 to 927 1 to 860       860/860
(100 %)
6 diff
(99.4 %id)
CR987008 T-Lymphocytes .e 71 to 972 1 to 904       904/904
(100 %)
2 diff
(99.8 %id)
CR600114 placenta .e 72 to 1400 1 to 1329 exact     1329/1329
(100 %)
0 diff
(100 %id)
ES311914 frontal balding hair, skin .e 72 to 289 1 to 215       215/215
(100 %)
4 diff
(98.2 %id)
BC001748.
matches multiple genes
lung, Lung, small cell carcinoma, small cell carcinoma .e 72 to 1425 170 to 1523 exact tiling clone, AAA also hits gene THOC6 1354/1523
(88 %)
6 diff
(99.7 %id)
BQ878690 ductal carcinoma, cell line, Pancreas .e 72 to 948 1 to 884       884/899
(98 %)
12 diff
(98.7 %id)
BQ900389 carcinoma, cell line, Prostate .e 72 to 966 1 to 895       895/896
(99 %)
2 diff
(99.8 %id)
BQ926716 large cell carcinoma, lung .e 72 to 956 1 to 893       893/936
(95 %)
12 diff
(98.8 %id)
BQ932490 leiomyosarcoma, uterus .e 72 to 958 1 to 893       891/893
(99 %)
7 diff
(99.3 %id)
ES309231 occipital hair of pubic hypotrichosispatient, skin .e 73 to 701 33 to 657       625/822
(76 %)
9 diff
(99.0 %id)
ES311075 scalp interfollicular dermis, skin .e 73 to 639 27 to 604       578/610
(94 %)
20 diff
(96.8 %id)
BM479147 melanotic melanoma, skin .e 73 to 956 1 to 888       888/1094
(81 %)
14 diff
(98.8 %id)
BQ225909 melanotic melanoma, skin .e 73 to 900 1 to 831       831/884
(94 %)
8 diff
(99.1 %id)
BU501427 eye, normal pigmented retinal epithelium .e 73 to 991 1 to 919       919/921
(99 %)
5 diff
(99.5 %id)
BQ924053 eye, normal pigmented retinal epithelium .e 73 to 971 1 to 901       901/902
(99 %)
8 diff
(99.2 %id)
CX873586 embryonic stem .e 73 to 926 1 to 854       854/854
(100 %)
0 diff
(100 %id)
DR759689 embryonic stem .e 73 to 938 1 to 866       866/866
(100 %)
0 diff
(100 %id)
CX163194 human embryonic stem cells differentiated toan early endodermal cell type .e 73 to 731 1 to 659   fully sequenced,   659/659
(100 %)
0 diff
(100 %id)
ES314780 occipital scalp hair, skin .e 74 to 297 1 to 225       223/225
(99 %)
1 diff
(99.6 %id)
BM457980 leiomyosarcoma, uterus .e 74 to 956 1 to 894       894/1049
(85 %)
16 diff
(98.5 %id)
BM800352 leiomyosarcoma, uterus .e 74 to 1019 1 to 950       948/1029
(92 %)
11 diff
(99.0 %id)
BM542255 melanotic melanoma, skin .e 74 to 900 1 to 827       827/961
(86 %)
8 diff
(99.2 %id)
BQ686050 ductal carcinoma, cell line, Pancreas .e 74 to 940 1 to 868       868/868
(100 %)
6 diff
(99.4 %id)
BQ690623 ductal carcinoma, cell line, Pancreas .e 74 to 955 1 to 883       883/939
(94 %)
5 diff
(99.5 %id)
BU540704 large cell carcinoma, lung .e 74 to 968 1 to 895       895/895
(100 %)
1 diff
(99.9 %id)
TI_57229308   .e 74 to 699 92 to 732       597/1008
(59 %)
19 diff
(98.2 %id)
TI_57229481   .e 74 to 829 10 to 762       753/762
(98 %)
11 diff
(98.6 %id)
TI_57230845   .e 74 to 912 47 to 883       837/837
(100 %)
6 diff
(99.3 %id)
TI_59387352   .e 74 to 728 104 to 760       657/857
(76 %)
8 diff
(99.1 %id)
CR993923 T-Lymphocytes .e 74 to 973 1 to 901       901/901
(100 %)
1 diff
(99.9 %id)
ES312365 frontal balding hair, skin .e 75 to 264 1 to 190       190/190
(100 %)
0 diff
(100 %id)
BQ477827 insulinoma, Pancreas .e 75 to 661 1 to 587       587/587
(100 %)
4 diff
(99.4 %id)
BU173155 leiomyosarcoma, uterus .e 75 to 922 1 to 854       854/877
(97 %)
14 diff
(98.5 %id)
BQ718740 sympathetic trunk .e 75 to 950 1 to 888       888/963
(92 %)
16 diff
(98.4 %id)
BQ719835 sympathetic trunk .e 75 to 900 1 to 827       827/914
(90 %)
6 diff
(99.4 %id)
TI_154188821   .e 75 to 955 52 to 918       867/994
(87 %)
17 diff
(98.3 %id)
BC009564 Pancreas, epithelioid carcinoma .e 76 to 1425 1 to 1350 V98L available from MGC, AAA   1350/1350
(100 %)
1 diff
(100.0 %id)
BC021114 Brain, neuroblastoma .e 76 to 1425 1 to 1350 exact available from MGC, AAA   1350/1350
(100 %)
0 diff
(100 %id)
ES310019 scalp interfollicular dermis, skin .e 76 to 545 1 to 470       470/502
(93 %)
2 diff
(99.7 %id)
BM462977 melanotic melanoma, skin .e 76 to 956 1 to 885       885/1095
(80 %)
10 diff
(99.1 %id)
BQ689144 ductal carcinoma, cell line, Pancreas .e 76 to 900 1 to 827       827/927
(89 %)
6 diff
(99.4 %id)
CX868490 embryonic stem .e 76 to 633 1 to 558       558/558
(100 %)
0 diff
(100 %id)
CR595469 Placenta Cot 25-normalized .e 77 to 1377 1 to 1301 exact     1301/1301
(100 %)
0 diff
(100 %id)
CR597904 B cells (Ramos cell line) Cot 25-normalized .e 77 to 1390 1 to 1314 exact     1314/1314
(100 %)
0 diff
(100 %id)
CR618857 Neuroblastoma Cot 50-normalized .e 77 to 1410 1 to 1334 exact     1334/1334
(100 %)
0 diff
(100 %id)
AL549430 placenta, Placenta Cot 25-normalized .e 77 to 731 1 to 655   fully sequenced,   655/655
(100 %)
0 diff
(100 %id)
BX403036   .e 77 to 671 1 to 595   fully sequenced,   595/595
(100 %)
0 diff
(100 %id)
BX444372 adult brain, brain .e 77 to 1069 1 to 991       991/991
(100 %)
10 diff
(99.0 %id)
CD515130 White Matter .e 77 to 993 1 to 920       920/925
(99 %)
6 diff
(99.4 %id)
BC068065 Skin, melanoma, melanotic .e 78 to 1425 1 to 1348 exact available from MGC, AAA   1348/1348
(100 %)
0 diff
(100 %id)
ES307763 beard hair, skin .e 78 to 288 1 to 211       211/211
(100 %)
0 diff
(100 %id)
ES308876 occipital hair of pubic hypotrichosispatient, skin .e 78 to 545 1 to 468       468/468
(100 %)
9 diff
(98.1 %id)
ES309025 occipital hair of pubic hypotrichosispatient, skin .e 78 to 579 1 to 502       502/502
(100 %)
5 diff
(99.1 %id)
ES309962 scalp interfollicular dermis, skin .e 78 to 541 1 to 463       463/463
(100 %)
12 diff
(97.5 %id)
ES310078 scalp interfollicular dermis, skin .e 78 to 541 1 to 466       466/466
(100 %)
3 diff
(99.4 %id)
ES310798 scalp interfollicular dermis, skin .e 78 to 385 1 to 308       308/308
(100 %)
0 diff
(100 %id)
ES311024 scalp interfollicular dermis, skin .e 78 to 560 1 to 483       483/491
(98 %)
6 diff
(98.8 %id)
ES313894 beard hair, skin .e 78 to 411 1 to 334       334/334
(100 %)
0 diff
(100 %id)
BM908764 astrocytoma grade IV, cell line, brain .e 78 to 1077 11 to 1017       1005/1163
(86 %)
23 diff
(98.1 %id)
BU145678 ductal carcinoma, cell line, Pancreas .e 78 to 948 1 to 880       878/918
(95 %)
10 diff
(99.0 %id)
BQ686392 ductal carcinoma, cell line, Pancreas .e 78 to 900 1 to 825       825/879
(93 %)
8 diff
(99.1 %id)
BQ951190 large cell carcinoma, lung .e 78 to 1042 1 to 963       963/964
(99 %)
25 diff
(97.5 %id)
BQ920688 carcinoma, cell line, Prostate .e 78 to 1041 1 to 972       972/983
(98 %)
22 diff
(97.8 %id)
BU541745 carcinoma, cell line, Prostate .e 78 to 955 1 to 879       879/887
(99 %)
4 diff
(99.6 %id)
CX866259 embryonic stem .e 78 to 921 1 to 844   fully sequenced,   844/844
(100 %)
0 diff
(100 %id)
TI_57231375   .e 78 to 890 96 to 906       811/811
(100 %)
10 diff
(98.8 %id)
BM549480 astrocytoma grade IV, cell line, brain .e 79 to 956 1 to 879       879/1138
(77 %)
14 diff
(98.8 %id)
BQ421411 epithelioid carcinoma, Pancreas .e 79 to 959 1 to 883       883/884
(99 %)
7 diff
(99.3 %id)
BU177222 melanotic melanoma, skin .e 79 to 956 1 to 882       882/943
(93 %)
11 diff
(98.9 %id)
BQ717264 sympathetic trunk .e 79 to 986 1 to 916       913/916
(99 %)
10 diff
(99.0 %id)
BQ720440 sympathetic trunk .e 79 to 956 1 to 884       884/888
(99 %)
12 diff
(98.7 %id)
TI_57172371   .e 79 to 851 29 to 806       776/832
(93 %)
22 diff
(97.4 %id)
BQ898242 epidermoid carcinoma, cell line, salivary gland .e 80 to 956 1 to 889       889/931
(95 %)
21 diff
(97.8 %id)
BQ957183 large cell carcinoma, lung .e 80 to 948 1 to 869       869/870
(99 %)
4 diff
(99.6 %id)
BQ918175 large cell carcinoma, lung .e 80 to 983 1 to 905       905/905
(100 %)
5 diff
(99.5 %id)
BU543264 carcinoma, cell line, Prostate .e 80 to 973 1 to 895       895/895
(100 %)
4 diff
(99.6 %id)
CX781476 human embryonic stem cells .e 80 to 942 1 to 863       863/863
(100 %)
0 diff
(100 %id)
TI_59386530   .e 80 to 792 105 to 834       730/895
(81 %)
24 diff
(97.4 %id)
CR984429 T-Lymphocytes .e 80 to 969 1 to 891       891/894
(99 %)
5 diff
(99.5 %id)
TI_154188858   .e 80 to 1072 51 to 1031       981/1039
(94 %)
27 diff
(97.5 %id)
TI_154193443   .e 80 to 886 51 to 851   AAA   801/994
(80 %)
8 diff
(99.2 %id)
TI_154189710   .e 81 to 900 51 to 867       817/1025
(79 %)
11 diff
(99.0 %id)
BU157929 ductal carcinoma, cell line, Pancreas .e 82 to 956 1 to 876       876/956
(91 %)
13 diff
(98.7 %id)
BQ691706 ductal carcinoma, cell line, Pancreas .e 82 to 922 1 to 855       855/887
(96 %)
16 diff
(98.2 %id)
BQ681893 melanotic melanoma, cell line, skin .e 82 to 900 1 to 820       820/956
(85 %)
7 diff
(99.3 %id)
BU848885 ovary, teratocarcinoma, cell line .e 82 to 956 1 to 880       880/896
(98 %)
15 diff
(98.4 %id)
BU859662 adenocarcinoma, cell line, breast .e 82 to 948 1 to 868       868/888
(97 %)
2 diff
(99.8 %id)
BU956825 adenocarcinoma, cell line, breast .e 82 to 943 1 to 867       867/904
(95 %)
6 diff
(99.4 %id)
TI_57229650   .e 82 to 641 82 to 645       564/571
(98 %)
9 diff
(98.5 %id)
TI_154189579   .e 82 to 885 51 to 850       800/1020
(78 %)
8 diff
(99.3 %id)
ES311099 scalp interfollicular dermis, skin .e 83 to 715 9 to 642       634/642
(98 %)
9 diff
(98.6 %id)
TI_154193597   .e 85 to 1040 51 to 994       944/1046
(90 %)
18 diff
(98.3 %id)
TI_154193712   .e 85 to 956 51 to 921       871/1039
(83 %)
19 diff
(98.2 %id)
ES314125 occipital scalp hair, skin .e 86 to 283 1 to 197       197/197
(100 %)
2 diff
(99.0 %id)
ES315629 occipital scalp hair, skin .e 86 to 241 1 to 156       156/156
(100 %)
0 diff
(100 %id)
BM799773 eye, retinoblastoma .e 87 to 1103 1 to 1018       1018/1088
(93 %)
13 diff
(98.9 %id)
TI_151766525   .e 88 to 709 99 to 720       622/1166
(53 %)
9 diff
(99.3 %id)
BU542699 carcinoma, cell line, Prostate .e 89 to 948 1 to 862       862/880
(97 %)
5 diff
(99.5 %id)
EL948696 eyeball .e 90 to 603 4 to 517       514/517
(99 %)
0 diff
(100 %id)
ES314604 occipital scalp hair, skin .e 91 to 328 1 to 238       238/238
(100 %)
2 diff
(99.2 %id)
BM511426 insulinoma, Pancreas .e 91 to 660 7 to 576       570/577
(98 %)
1 diff
(99.9 %id)
BQ631418 Pancreas, Purified pancreatic islet .e 93 to 729 1 to 637       637/638
(99 %)
2 diff
(99.7 %id)
BM686157 eye, RPE and Choroid .e 94 to 557 1 to 464       464/464
(100 %)
0 diff
(100 %id)
BQ427941 leiomyosarcoma, uterus .e 95 to 897 1 to 808       808/861
(93 %)
11 diff
(98.8 %id)
BM559125 amelanotic melanoma, cell line, skin .e 96 to 950 1 to 867       867/1022
(84 %)
15 diff
(98.6 %id)
BM846945.
matches multiple genes
myeloma .e 96 to 199 1 to 104     also hits gene ANXA2P2 104/104
(100 %)
0 diff
(100 %id)
CR595032 Placenta Cot 25-normalized .e 98 to 1400 1 to 1303 exact     1303/1303
(100 %)
0 diff
(100 %id)
CR608031 T cells (Jurkat cell line) Cot10-normalized .e 98 to 1395 1 to 1298 exact     1298/1298
(100 %)
0 diff
(100 %id)
BE744791 adenocarcinoma cell line, ovary .e 98 to 793 1 to 700       700/873
(80 %)
9 diff
(99.0 %id)
BE792746 lung, small cell carcinoma .e 98 to 956 1 to 859       859/883
(97 %)
14 diff
(98.5 %id)
AL574058 placenta, Placenta Cot 25-normalized .e 610 to 1399 789 to 1   fully sequenced,   789/789
(100 %)
3 diff
(99.7 %id)
AL576319 placenta, Placenta Cot 25-normalized .e 610 to 1407 796 to 1   fully sequenced,   796/796
(100 %)
5 diff
(99.4 %id)
BX403035   .e 610 to 1390 780 to 1   fully sequenced,   780/780
(100 %)
4 diff
(99.5 %id)
BG744665 blood, natural killer cells, cell line .e 610 to 1359 773 to 23   fully sequenced,   751/773
(97 %)
0 diff
(100 %id)
AL540331 placenta .e 670 to 1396 727 to 1   fully sequenced,   727/727
(100 %)
2 diff
(99.8 %id)
AL573731 placenta, Placenta Cot 25-normalized .e 670 to 1377 710 to 1   fully sequenced,   710/710
(100 %)
9 diff
(98.8 %id)
CX163112 human embryonic stem cells differentiated toan early endodermal cell type .e 670 to 1425 783 to 28   fully sequenced, AAA   756/756
(100 %)
0 diff
(100 %id)
BM041819 Kidney, Wilms' tumor, cell line .e 745 to 1353 613 to 1   fully sequenced,   613/613
(100 %)
5 diff
(99.2 %id)
BQ477406 insulinoma, Pancreas .e 793 to 1425 650 to 18   AAA   633/638
(99 %)
0 diff
(100 %id)
TI_59395844   .e 820 to 1374 572 to 1       572/1107
(51 %)
30 diff
(97.3 %id)
CX866180 embryonic stem .e 860 to 1425 593 to 28   fully sequenced, AAA   566/566
(100 %)
1 diff
(99.9 %id)
CX868416 embryonic stem .e 885 to 1431 573 to 27   AAA   547/547
(100 %)
2 diff
(99.7 %id)
DC426568   .e 890 to 1425 541 to 1       538/542
(99 %)
14 diff
(97.5 %id)
BM662701 eye, RPE and Choroid .e 927 to 1427 518 to 18   AAA   501/501
(100 %)
0 diff
(100 %id)
BQ631138 Pancreas, Purified pancreatic islet .e 969 to 1424 456 to 1       456/456
(100 %)
0 diff
(100 %id)
DB383384   .e 975 to 1425 453 to 1       453/462
(98 %)
3 diff
(99.4 %id)
CX868414 embryonic stem .e 995 to 1426 459 to 28   AAA   432/432
(100 %)
4 diff
(99.1 %id)
BM510596 insulinoma, Pancreas .e 1007 to 1618 627 to 16   AAA   612/612
(100 %)
0 diff
(100 %id)
AU135946 placenta .f 1 to 738 2 to 742   tiling clone, capped   741/764
(96 %)
13 diff
(98.3 %id)
AU121244 whole embryo, mainly body .f 3 to 736 2 to 735   capped   734/780
(94 %)
7 diff
(99.2 %id)
BE616283 adenocarcinoma, Pancreas .f 11 to 734 40 to 755       716/1004
(71 %)
20 diff
(98.1 %id)
TI_59394840   .f 11 to 738 108 to 853       746/939
(79 %)
40 diff
(95.8 %id)
TI_57233346   .f 12 to 736 24 to 741       718/754
(95 %)
14 diff
(98.2 %id)
BG036224 adenocarcinoma, cell line, Prostate .f 14 to 753 1 to 746       746/767
(97 %)
23 diff
(97.1 %id)
BG166487 hypernephroma, cell line, Kidney .f 15 to 736 1 to 721       721/954
(75 %)
21 diff
(97.8 %id)
BG739906 skin .f 15 to 738 1 to 724       724/905
(80 %)
7 diff
(99.3 %id)
BG390124 embryonal carcinoma, cell line, testis .f 17 to 742 12 to 735       724/999
(72 %)
15 diff
(98.5 %id)
BF313160 brain, neuroblastoma .f 19 to 736 1 to 719       719/909
(79 %)
19 diff
(98.0 %id)
BG122901 adenocarcinoma, cell line, Liver .f 19 to 736 1 to 711       709/845
(83 %)
20 diff
(97.7 %id)
BG119681 adenocarcinoma, cell line, Liver .f 19 to 747 1 to 727   tiling clone,   727/984
(73 %)
13 diff
(98.7 %id)
BG163578 hypernephroma, cell line, Kidney .f 19 to 738 1 to 722       722/846
(85 %)
17 diff
(98.0 %id)
BG167862 hypernephroma, cell line, Kidney .f 19 to 736 1 to 717       717/931
(77 %)
12 diff
(98.8 %id)
BG331338 large cell carcinoma, lung .f 19 to 741 1 to 715       715/951
(75 %)
24 diff
(97.5 %id)
BG475819 melanotic melanoma, skin .f 19 to 734 1 to 728       726/863
(84 %)
26 diff
(97.0 %id)
BG748164 eye, normal pigmented retinal epithelium .f 19 to 736 1 to 717       717/833
(86 %)
7 diff
(99.2 %id)
BG764007 melanotic melanoma, high MDR (cell line), skin .f 19 to 736 1 to 719       719/726
(99 %)
7 diff
(99.1 %id)
BI160829 epithelioid carcinoma cell line, Pancreas .f 19 to 736 1 to 730       728/845
(86 %)
23 diff
(97.3 %id)
BI906873 leukocyte .f 19 to 736 1 to 713       713/726
(98 %)
11 diff
(98.5 %id)
BM048677 carcinoma, cell line, Prostate .f 19 to 738 1 to 721       721/743
(97 %)
7 diff
(99.1 %id)
BM047514 carcinoma, cell line, Prostate .f 19 to 734 1 to 721       721/883
(81 %)
20 diff
(97.8 %id)
BM472467 embryonal carcinoma, cell line, testis .f 19 to 737 1 to 720       720/1006
(71 %)
11 diff
(99.0 %id)
BE568274 bladder, carcinoma, cell line .f 20 to 740 1 to 709   tiling clone,   709/738
(96 %)
23 diff
(96.9 %id)
BF030710 hypernephroma, Kidney .f 20 to 736 1 to 714       714/747
(95 %)
32 diff
(95.8 %id)
BG324019 Kidney, renal cell adenocarcinoma .f 20 to 736 1 to 711       711/945
(75 %)
13 diff
(98.7 %id)
BG425224 Kidney, renal cell adenocarcinoma .f 20 to 744 1 to 726       726/765
(94 %)
14 diff
(98.2 %id)
BG420693 Kidney, renal cell adenocarcinoma .f 20 to 737 1 to 717       717/938
(76 %)
11 diff
(98.9 %id)
BG437431 large cell carcinoma, lung .f 20 to 738 1 to 727       727/771
(94 %)
18 diff
(97.7 %id)
BM807684 amelanotic melanoma, cell line, skin .f 20 to 736 1 to 719       719/1110
(64 %)
20 diff
(98.2 %id)
BQ896834 ductal carcinoma, cell line, Pancreas .f 20 to 736 1 to 719       719/959
(74 %)
15 diff
(98.5 %id)
TI_59389497   .f 20 to 736 94 to 811       718/958
(74 %)
5 diff
(99.5 %id)
BF973956 leiomyosarcoma cell line, uterus .f 21 to 737 1 to 721       721/860
(83 %)
7 diff
(99.2 %id)
BG169135 hypernephroma, cell line, Kidney .f 21 to 736 1 to 712       712/900
(79 %)
12 diff
(98.7 %id)
BG120581 adenocarcinoma, cell line, Liver .f 21 to 743 1 to 719       719/969
(74 %)
16 diff
(98.4 %id)
BG118967 adenocarcinoma, cell line, Liver .f 21 to 736 1 to 710       710/943
(75 %)
24 diff
(97.5 %id)
BE874795 large cell carcinoma, undifferentiated, lung .f 22 to 744 1 to 724       724/1107
(65 %)
24 diff
(97.9 %id)
BG249939 hypernephroma, cell line, Kidney .f 22 to 734 1 to 707       705/963
(73 %)
17 diff
(98.3 %id)
BG252473 adenocarcinoma, cell line, Liver .f 22 to 738 1 to 720       720/1078
(66 %)
13 diff
(98.8 %id)
BU174850 ductal carcinoma, cell line, Pancreas .f 22 to 738 27 to 750       722/1017
(70 %)
19 diff
(98.2 %id)
CF126650 Chondrosarcoma Lung Metastasis cell lines, lung .f 22 to 736 1 to 714   tiling clone,   714/722
(98 %)
3 diff
(99.6 %id)
BG119076 adenocarcinoma, cell line, Liver .f 24 to 738 1 to 721       721/886
(81 %)
12 diff
(98.7 %id)
BF205074 muscle, rhabdomyosarcoma .f 27 to 736 1 to 710       710/854
(83 %)
11 diff
(98.8 %id)
BF308797 muscle, rhabdomyosarcoma .f 27 to 738 1 to 716       716/908
(78 %)
17 diff
(98.2 %id)
TI_154188995   .f 28 to 736 52 to 761       710/1015
(69 %)
22 diff
(97.9 %id)
BU509747 leiomyosarcoma, uterus .f 30 to 736 1 to 708       708/865
(81 %)
18 diff
(98.0 %id)
BF124975 melanotic melanoma, skin .f 32 to 736 1 to 706       706/1009
(69 %)
14 diff
(98.7 %id)
BE539994 cervix .f 34 to 738 1 to 702       702/767
(91 %)
18 diff
(97.7 %id)
BE877864 large cell carcinoma, undifferentiated, lung .f 34 to 738 1 to 716       714/940
(75 %)
15 diff
(98.5 %id)
BE546769 cervical carcinoma cell line, cervix .f 35 to 736 1 to 705       705/857
(82 %)
27 diff
(96.9 %id)
BE745293 adenocarcinoma cell line, ovary .f 35 to 736 1 to 692       692/969
(71 %)
26 diff
(97.4 %id)
BF036512 adenocarcinoma, ovary .f 35 to 738 1 to 704       704/943
(74 %)
14 diff
(98.6 %id)
BE884380 leiomyosarcoma, uterus .f 36 to 738 1 to 704       704/797
(88 %)
14 diff
(98.3 %id)
BE741289 adenocarcinoma cell line, ovary .f 36 to 736 1 to 703       703/850
(82 %)
9 diff
(99.0 %id)
BE385626 melanotic melanoma, skin .f 37 to 742 1 to 704       704/739
(95 %)
23 diff
(96.9 %id)
BF036621 adenocarcinoma, ovary .f 37 to 734 1 to 690       690/880
(78 %)
18 diff
(98.0 %id)
BE884949 leiomyosarcoma, uterus .f 37 to 736 1 to 687       687/880
(78 %)
23 diff
(97.4 %id)
BE735945 adenocarcinoma, Pancreas .f 38 to 738 1 to 705       705/865
(81 %)
15 diff
(98.3 %id)
BE729450 melanotic melanoma, skin .f 39 to 738 1 to 706       706/788
(89 %)
11 diff
(98.7 %id)
BE742437 adenocarcinoma cell line, ovary .f 39 to 736 1 to 699       699/749
(93 %)
7 diff
(99.1 %id)
BE277277 melanotic melanoma, skin .f 40 to 734 1 to 695       695/827
(84 %)
10 diff
(98.8 %id)
BE273261.
matches multiple genes
Kidney, renal cell adenocarcinoma .f 40 to 736 7 to 700     also hits gene ANXA2P2 694/710
(97 %)
28 diff
(96.1 %id)
BE615967 adenocarcinoma, Pancreas .f 40 to 736 8 to 710       703/861
(81 %)
17 diff
(98.1 %id)
BE735789 adenocarcinoma, Pancreas .f 40 to 736 1 to 694       694/992
(69 %)
12 diff
(98.8 %id)
BE744196 adenocarcinoma cell line, ovary .f 40 to 738 1 to 697       697/937
(74 %)
4 diff
(99.6 %id)
BE909707 epithelioid carcinoma, Pancreas .f 40 to 742 9 to 723       657/789
(83 %)
30 diff
(96.2 %id)
BF026946 melanotic melanoma, skin .f 40 to 738 1 to 696       696/954
(72 %)
12 diff
(98.8 %id)
BG740224 skin .f 40 to 738 21 to 721       701/733
(95 %)
12 diff
(98.4 %id)
CN407805 embryonic stem cells, DMSO-treated H9 cellline .f 42 to 736 1 to 695       695/703
(98 %)
3 diff
(99.6 %id)
BE885165 leiomyosarcoma, uterus .f 42 to 746 1 to 704       704/732
(96 %)
15 diff
(98.0 %id)
BF026198 melanotic melanoma, skin .f 42 to 738 1 to 688       688/965
(71 %)
14 diff
(98.6 %id)
BE906304 epithelioid carcinoma, Pancreas .f 43 to 736 1 to 697       697/822
(84 %)
12 diff
(98.6 %id)
BG192878   .f 44 to 734 1 to 691       691/793
(87 %)
4 diff
(99.5 %id)
BU180400 melanotic melanoma, cell line, skin .f 44 to 735 46 to 740       695/951
(73 %)
19 diff
(98.1 %id)
BG035256 adenocarcinoma, cell line, Liver .f 45 to 735 14 to 707       694/919
(75 %)
17 diff
(98.2 %id)
BQ893414 ductal carcinoma, cell line, Pancreas .f 46 to 738 1 to 694       694/853
(81 %)
6 diff
(99.3 %id)
BQ897752 ductal carcinoma, cell line, Pancreas .f 46 to 736 1 to 691       691/950
(72 %)
11 diff
(98.9 %id)
BQ901111 ductal carcinoma, cell line, Pancreas .f 46 to 736 1 to 690       690/967
(71 %)
10 diff
(99.0 %id)
BQ961331 carcinoma, cell line, Prostate .f 47 to 737 1 to 696       696/1019
(68 %)
25 diff
(97.6 %id)
BG252559 adenocarcinoma, cell line, Liver .f 49 to 736 1 to 686       686/744
(92 %)
8 diff
(99.0 %id)
BF035190 adenocarcinoma, ovary .f 50 to 736 1 to 680       680/906
(75 %)
18 diff
(98.1 %id)
BI870025 adenocarcinoma, cell line, Liver .f 51 to 736 1 to 686       686/690
(99 %)
3 diff
(99.6 %id)
TI_57229615   .f 51 to 736 88 to 773       686/690
(99 %)
3 diff
(99.6 %id)
BE741969 adenocarcinoma cell line, ovary .f 54 to 736 1 to 686       686/916
(74 %)
13 diff
(98.6 %id)
BF038063 adenocarcinoma, ovary .f 103 to 736 13 to 639       627/940
(66 %)
14 diff
(98.6 %id)
BG333998 melanotic melanoma, skin .f 103 to 736 90 to 744       655/909
(72 %)
27 diff
(97.1 %id)
BI868980 adenocarcinoma, cell line, Liver .f 223 to 738 1 to 517       517/743
(69 %)
8 diff
(99.0 %id)
TI_57230571   .f 223 to 738 57 to 573       517/743
(69 %)
8 diff
(99.0 %id)
TI_154061712   .f 635 to 1361 823 to 96   tiling clone, AAA   729/975
(74 %)
11 diff
(98.9 %id)
TI_154115415   .f 637 to 1361 820 to 95   AAA   727/952
(76 %)
7 diff
(99.3 %id)
AU147098 whole embryo, mainly body .f 826 to 1361 533 to 1       533/545
(97 %)
8 diff
(98.6 %id)
DB374351 placenta .f 886 to 1361 473 to 1       473/516
(91 %)
20 diff
(96.2 %id)
CA453395 mixed (pool of 40 RNAs) .g 1 to 757 3 to 761   tiling clone,   759/768
(98 %)
14 diff
(98.2 %id)
BF246607 brain, glioblastoma .g 1 to 632 2 to 632       632/901
(70 %)
27 diff
(97.1 %id)
BF244428 brain, glioblastoma .g 1 to 537 1 to 536       536/536
(100 %)
4 diff
(99.3 %id)
BF215658 brain, glioblastoma .g 1 to 682 1 to 680       678/777
(87 %)
24 diff
(97.0 %id)
BF668621 brain, primitive neuroectoderm .g 3 to 616 1 to 605       605/842
(71 %)
14 diff
(98.4 %id)
BF035776 adenocarcinoma, ovary .g 7 to 661 1 to 655       655/656
(99 %)
7 diff
(99.0 %id)
BQ223672 large cell carcinoma, lung .g 17 to 741 1 to 732       732/895
(81 %)
11 diff
(98.8 %id)
BQ949457 large cell carcinoma, lung .g 17 to 923 1 to 910   tiling clone,   910/912
(99 %)
13 diff
(98.6 %id)
AA314335 colon .g 20 to 461 1 to 442       442/442
(100 %)
0 diff
(100 %id)
BE145704 head_neck .g 878 to 1249 12 to 380   tiling clone,   369/381
(96 %)
11 diff
(97.2 %id)
BF353718 head_neck .g 910 to 1210 303 to 3   tiling clone,   301/303
(99 %)
0 diff
(100 %id)
BI013305 lung_tumor .g 965 to 1093 5 to 136       132/136
(97 %)
6 diff
(95.6 %id)
BG675885 skin, squamous cell carcinoma .g 998 to 1780 1 to 793   tiling clone,   793/794
(99 %)
39 diff
(95.1 %id)
CD518366 White Matter .g 1363 to 2184 33 to 866   tiling clone,   834/887
(94 %)
24 diff
(97.3 %id)
BQ722301 sympathetic trunk .g 1379 to 2239 26 to 889       864/890
(97 %)
8 diff
(99.2 %id)
BQ722510 sympathetic trunk .g 1478 to 2351 1 to 901       901/978
(92 %)
39 diff
(96.1 %id)
BF375153 stomach .g 1538 to 1839 1 to 302       302/308
(98 %)
4 diff
(98.8 %id)
CV309406 breast_normal .g 1572 to 1716 1 to 149       149/151
(98 %)
10 diff
(93.4 %id)
ES310511 scalp interfollicular dermis, skin .g 1613 to 2171 1 to 562       562/562
(100 %)
8 diff
(98.6 %id)
BE182622 head_neck .g 1836 to 2015 189 to 11     Submitted on the opposite strand 179/196
(91 %)
0 diff
(100 %id)
BM700391 eye, lens .g 1906 to 2198 1 to 293   fully sequenced,   293/293
(100 %)
1 diff
(99.7 %id)
BU616312 Bone, Subchondral Bone .g 1917 to 2654 756 to 19   tiling clone, AAA   738/738
(100 %)
0 diff
(100 %id)
BQ719561 sympathetic trunk .g 1929 to 2664 1 to 736   tiling clone, AAA   736/736
(100 %)
4 diff
(99.5 %id)
CU451978 epidermis .g 1944 to 2111 170 to 2     Submitted on the opposite strand 169/179
(94 %)
0 diff
(100 %id)
H41944 breast .g 1959 to 2309 1 to 357   fully sequenced,   357/357
(100 %)
5 diff
(98.6 %id)
BU738046 eye, lens .g 2168 to 2654 505 to 19   fully sequenced, AAA   487/487
(100 %)
0 diff
(100 %id)
DW424771 Liver .g 2170 to 2443 14 to 287       274/287
(95 %)
6 diff
(98.0 %id)
AW970677   .g 2203 to 2653 451 to 1     Submitted on the opposite strand 451/603
(74 %)
0 diff
(100 %id)
AW803324 uterus .g 2235 to 2604 394 to 25       370/394
(93 %)
0 diff
(100 %id)
AA524331 colon .g 2240 to 2654 416 to 1       416/416
(100 %)
1 diff
(99.8 %id)
H41905 breast .g 2279 to 2655 394 to 3   tiling clone, fully sequenced,   392/394
(99 %)
9 diff
(97.8 %id)
CU443571 epidermis .h 1 to 750 11 to 760   tiling clone,   750/760
(98 %)
7 diff
(99.1 %id)
CU453615 epidermis .h 1 to 734 11 to 744   tiling clone,   734/749
(97 %)
8 diff
(99.0 %id)
DC408721 thymus .h 464 to 997 1 to 534   tiling clone,   534/534
(100 %)
1 diff
(99.9 %id)
BX479799   .h 908 to 1272 1 to 365   tiling clone,   365/365
(100 %)
0 diff
(100 %id)
CF595455 Stomach, adenocarcinoma .i 1 to 746 1 to 751   tiling clone,   751/753
(99 %)
21 diff
(97.3 %id)
CF595529 Stomach, adenocarcinoma .i 4 to 746 1 to 748       748/763
(98 %)
18 diff
(97.7 %id)
CF595513 Stomach, adenocarcinoma .i 4 to 744 1 to 742       742/747
(99 %)
10 diff
(98.7 %id)
CF595505 Stomach, adenocarcinoma .i 4 to 744 1 to 742       742/760
(97 %)
10 diff
(98.7 %id)
CF595954 Stomach, adenocarcinoma .i 4 to 746 1 to 755   tiling clone,   755/790
(95 %)
27 diff
(96.6 %id)
CF596454 Stomach, adenocarcinoma .i 4 to 744 1 to 748       748/785
(95 %)
20 diff
(97.5 %id)
CF596806 ovary .i 4 to 776 1 to 785 N58Q I59H L60F T61D N62Q ...     785/786
(99 %)
33 diff
(95.9 %id)
CF596596 ovary .i 4 to 746 1 to 745       745/766
(97 %)
19 diff
(97.6 %id)
BQ277321 mixed (pool of 40 RNAs) .i 5 to 744 1 to 746       746/908
(82 %)
29 diff
(96.9 %id)
BU177536 bone marrow, from acute myelogenous leukemia .i 5 to 746 1 to 749       749/785
(95 %)
18 diff
(97.8 %id)
BU571027 brain, glioblastoma .i 5 to 744 1 to 742       742/809
(91 %)
9 diff
(98.9 %id)
BU571088 brain, glioblastoma .i 5 to 743 1 to 754       754/840
(89 %)
34 diff
(96.0 %id)
BU940300 mixed (pool of 40 RNAs) .i 5 to 744 1 to 744       744/777
(95 %)
11 diff
(98.6 %id)
BU941663 mixed (pool of 40 RNAs) .i 5 to 745 1 to 744   tiling clone,   744/749
(99 %)
17 diff
(97.8 %id)
CB962471 Blood vessels - aorta, basilar and artery .i 5 to 743 1 to 743       743/790
(94 %)
17 diff
(97.9 %id)
CB955962 Pooled-Glandular .i 5 to 742 1 to 741       741/790
(93 %)
12 diff
(98.5 %id)
CD105122 Pooled-Skin .i 5 to 746 1 to 747       747/750
(99 %)
25 diff
(96.7 %id)
CD357023 Blood vessels - aorta, basilar and artery .i 5 to 746 1 to 743       743/746
(99 %)
12 diff
(98.4 %id)
CD356471 Blood vessels - aorta, basilar and artery .i 5 to 744 1 to 742       742/761
(97 %)
8 diff
(99.0 %id)
CD511932 Pooled-Skin .i 5 to 746 1 to 749       749/766
(97 %)
17 diff
(97.8 %id)
CD640844 pooled .i 5 to 742 1 to 733       733/755
(97 %)
20 diff
(97.4 %id)
ES309727 occipital hair of pubic hypotrichosispatient, skin .i 6 to 746 1 to 735       735/759
(96 %)
21 diff
(97.3 %id)
BG497981 adenocarcinoma, Prostate .i 6 to 752 1 to 758       758/897
(84 %)
37 diff
(95.9 %id)
BU943203 mixed (pool of 40 RNAs) .i 6 to 744 1 to 741       741/766
(96 %)
8 diff
(99.0 %id)
CB963295 Blood vessels - aorta, basilar and artery .i 6 to 746 1 to 746       746/788
(94 %)
17 diff
(97.9 %id)
CD522887 pooled .i 6 to 746 1 to 740       740/823
(89 %)
9 diff
(99.0 %id)
BG400837 Kidney .i 7 to 746 1 to 745       745/886
(84 %)
14 diff
(98.5 %id)
BG434762 placenta .i 7 to 746 1 to 755       751/801
(93 %)
18 diff
(97.8 %id)
BG483841 lung .i 7 to 744 1 to 743       743/784
(94 %)
22 diff
(97.2 %id)
BG504625 embryonal carcinoma, testis .i 7 to 746 1 to 747       747/818
(91 %)
15 diff
(98.2 %id)
BG500990 adenocarcinoma, Prostate .i 7 to 746 1 to 744       744/781
(95 %)
12 diff
(98.5 %id)
BG500853 adenocarcinoma, Prostate .i 7 to 744 1 to 748       748/789
(94 %)
26 diff
(96.8 %id)
BG541978 lung .i 7 to 744 1 to 739       739/749
(98 %)
8 diff
(99.0 %id)
BG530170 embryonal carcinoma, testis .i 7 to 744 1 to 739       739/870
(84 %)
11 diff
(98.8 %id)
BG532321 embryonal carcinoma, testis .i 7 to 746 1 to 740       740/753
(98 %)
5 diff
(99.4 %id)
BG547612 lung .i 7 to 744 1 to 740       740/775
(95 %)
9 diff
(98.9 %id)
BG566735 Liver .i 7 to 744 1 to 739       739/779
(94 %)
12 diff
(98.5 %id)
BG569751 lung .i 7 to 743 1 to 744       744/791
(94 %)
24 diff
(97.0 %id)
BG687628 lung, mucoepidermoid carcinoma .i 7 to 752 1 to 752       752/799
(94 %)
19 diff
(97.7 %id)
BG623003 placenta .i 7 to 746 1 to 745       745/846
(88 %)
16 diff
(98.2 %id)
BG778658 adenocarcinoma, Prostate .i 7 to 746 1 to 756       756/831
(90 %)
35 diff
(95.8 %id)
BG776044 lung, mucoepidermoid carcinoma .i 7 to 746 1 to 744       744/852
(87 %)
17 diff
(98.1 %id)
BG771071 adenocarcinoma, Prostate .i 7 to 746 1 to 740       740/743
(99 %)
10 diff
(98.7 %id)
BU166116 bone marrow, from acute myelogenous leukemia .i 7 to 743 1 to 744       744/800
(93 %)
13 diff
(98.4 %id)
BU943234 mixed (pool of 40 RNAs) .i 7 to 746 1 to 742       742/779
(95 %)
10 diff
(98.8 %id)
AU123458   .i 7 to 744 2 to 741   capped   740/809
(91 %)
9 diff
(98.9 %id)
BF382834 brain, primitive neuroectoderm .i 8 to 751 1 to 757       755/760
(99 %)
53 diff
(93.1 %id)
BF541165 hypernephroma, Kidney .i 8 to 744 1 to 727       727/846
(85 %)
38 diff
(95.6 %id)
BG483204 lung .i 8 to 744 1 to 742       740/749
(98 %)
11 diff
(98.6 %id)
BG563220 Liver .i 8 to 746 1 to 748   tiling clone,   748/923
(81 %)
15 diff
(98.4 %id)
BG611048 adenocarcinoma, Prostate .i 8 to 746 1 to 743       741/855
(86 %)
10 diff
(98.9 %id)
BG611279 adenocarcinoma, Prostate .i 8 to 746 1 to 749       749/767
(97 %)
25 diff
(96.8 %id)
TI_154091176   .i 8 to 744 54 to 785     Submitted on the opposite strand 732/946
(77 %)
17 diff
(98.3 %id)
DB246708   .i 9 to 746 2 to 742   capped   741/846
(87 %)
9 diff
(99.0 %id)
BF244761 brain, glioblastoma .i 10 to 750 1 to 729       729/899
(81 %)
36 diff
(96.0 %id)
CX756803 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .i 17 to 742 1 to 721     Submitted on the opposite strand 721/855
(84 %)
7 diff
(99.2 %id)
CN407883 embryonic stem cells, cell lines H1, H7, andH9 .i 19 to 744 1 to 727       727/735
(98 %)
3 diff
(99.6 %id)
BG117094 adenocarcinoma, cell line, Liver .i 19 to 742 1 to 723       723/1057
(68 %)
16 diff
(98.5 %id)
BG026724 Bone, osteosarcoma, cell line .i 20 to 746 1 to 723       723/932
(77 %)
16 diff
(98.3 %id)
BG830779 epithelioid carcinoma cell line, Pancreas .i 20 to 744 1 to 728       728/746
(97 %)
10 diff
(98.7 %id)
BG108366 Bone, osteosarcoma, cell line .i 21 to 744 1 to 725       725/949
(76 %)
7 diff
(99.3 %id)
BG166527 hypernephroma, cell line, Kidney .i 21 to 744 1 to 723       723/841
(85 %)
9 diff
(99.0 %id)
BG252000 adenocarcinoma, cell line, Liver .i 21 to 744 1 to 722       722/938
(76 %)
8 diff
(99.2 %id)
BG252215 adenocarcinoma, cell line, Liver .i 21 to 744 10 to 733       724/845
(85 %)
18 diff
(97.9 %id)
BG334290 melanotic melanoma, skin .i 21 to 744 1 to 727       727/931
(78 %)
18 diff
(98.1 %id)
BG423140 Kidney, renal cell adenocarcinoma .i 21 to 743 1 to 726       724/916
(79 %)
20 diff
(97.9 %id)
BI916834 brain .i 21 to 744 1 to 727       727/801
(90 %)
9 diff
(98.9 %id)
BM048188 carcinoma, cell line, Prostate .i 21 to 744 1 to 728       728/904
(80 %)
9 diff
(99.1 %id)
BQ933204 epidermoid carcinoma, cell line, lung .i 21 to 744 1 to 730       730/947
(77 %)
18 diff
(98.1 %id)
BG171670 hypernephroma, cell line, Kidney .i 22 to 749 1 to 726       726/756
(96 %)
16 diff
(97.9 %id)
BI256352 cervical carcinoma cell line, cervix .i 22 to 743 1 to 725       725/914
(79 %)
13 diff
(98.6 %id)
BQ935511 carcinoma, cell line, Prostate .i 22 to 743 1 to 729       729/970
(75 %)
30 diff
(97.0 %id)
BQ923224 epidermoid carcinoma, cell line, lung .i 22 to 746 1 to 727       727/916
(79 %)
11 diff
(98.8 %id)
BQ961127 carcinoma, cell line, Prostate .i 22 to 745 1 to 725       725/950
(76 %)
5 diff
(99.5 %id)
BM698460 eye, fetal eyes .i 22 to 494 1 to 472       472/472
(100 %)
1 diff
(99.8 %id)
BQ222436 embryonal carcinoma, cell line, testis .i 23 to 744 1 to 722   tiling clone,   722/860
(83 %)
4 diff
(99.6 %id)
BU783644 insulinoma, Pancreas .i 23 to 647 1 to 625       625/625
(100 %)
3 diff
(99.6 %id)
BE905738 epithelioid carcinoma, Pancreas .i 24 to 746 1 to 729       729/1033
(70 %)
15 diff
(98.6 %id)
BG108036 Bone, osteosarcoma, cell line .i 24 to 744 1 to 719       719/931
(77 %)
7 diff
(99.3 %id)
BG117666 adenocarcinoma, cell line, Liver .i 24 to 746 1 to 726       726/825
(88 %)
11 diff
(98.7 %id)
BI087573 cervix .i 24 to 746 1 to 725       725/889
(81 %)
11 diff
(98.8 %id)
BM046108 carcinoma, cell line, Prostate .i 25 to 746 1 to 726       726/901
(80 %)
10 diff
(98.9 %id)
BQ228054 epithelioid carcinoma, Pancreas .i 25 to 743 1 to 721       721/929
(77 %)
13 diff
(98.7 %id)
BQ222304 epithelioid carcinoma, Pancreas .i 25 to 744 1 to 721       721/860
(83 %)
6 diff
(99.4 %id)
BM708170 eye, RPE and Choroid .i 41 to 505 1 to 465       465/465
(100 %)
0 diff
(100 %id)
TI_154022644   .i 684 to 1379 773 to 88   AAA   686/690
(99 %)
7 diff
(99.0 %id)
BU782657 insulinoma, Pancreas .i 732 to 1379 666 to 20   tiling clone, AAA   647/647
(100 %)
3 diff
(99.6 %id)
BU732017 eye, RPE and Choroid .i 761 to 1379 637 to 19   AAA   619/619
(100 %)
0 diff
(100 %id)
BM667380 eye, fetal eyes .i 780 to 1379 618 to 19   AAA   600/600
(100 %)
0 diff
(100 %id)
AK124427 bladder .j 1 to 2338 2 to 2337 exact tiling clone, available from FLJ, AAA   2337/2337
(100 %)
7 diff
(99.8 %id)
DA044717 bladder .j 1 to 493 2 to 496   capped   495/495
(100 %)
4 diff
(99.2 %id)
BE736579 adenocarcinoma, Pancreas .j 1066 to 1803 1 to 731       731/920
(79 %)
25 diff
(97.3 %id)
DB296111 bladder .j 1839 to 2338 500 to 1       500/500
(100 %)
0 diff
(100 %id)
EY198498 intestinal (Lauren) gastric adenocarcinoma, stomach .k 1 to 400 8 to 407       406/407
(99 %)
6 diff
(98.6 %id)
BG505065 embryonal carcinoma, testis .k 1 to 666 7 to 672       672/678
(99 %)
3 diff
(99.6 %id)
CF595738 Stomach, adenocarcinoma .k 1 to 666 4 to 674       674/772
(87 %)
14 diff
(98.2 %id)
BU171984 bone marrow, from acute myelogenous leukemia .k 1 to 665 3 to 671       671/817
(82 %)
11 diff
(98.7 %id)
CD511592 Blood vessels - aorta, basilar and artery .k 1 to 734 3 to 742   tiling clone,   742/747
(99 %)
15 diff
(98.0 %id)
BM742809 stomach .k 1 to 652 3 to 653       653/653
(100 %)
4 diff
(99.4 %id)
BM745862 stomach .k 1 to 603 3 to 605       605/605
(100 %)
3 diff
(99.6 %id)
BM784170 stomach .k 1 to 656 3 to 658       658/658
(100 %)
3 diff
(99.6 %id)
D28364 Fibrosarcoma .k 1 to 143 2 to 144       144/144
(100 %)
2 diff
(98.7 %id)
BQ432758 bone marrow, from acute myelogenous leukemia .k 1 to 782 2 to 784       784/785
(99 %)
8 diff
(99.0 %id)
BM741240 stomach .k 1 to 534 2 to 535       535/535
(100 %)
6 diff
(98.9 %id)
BG505150 embryonal carcinoma, testis .k 1 to 815 1 to 817       817/817
(100 %)
22 diff
(97.4 %id)
BG493587 lung, mucoepidermoid carcinoma .k 1 to 666 1 to 672       672/932
(72 %)
11 diff
(98.9 %id)
BG537527 lung .k 1 to 671 1 to 678       678/887
(76 %)
20 diff
(97.8 %id)
BG542994 lung .k 1 to 666 1 to 670       670/833
(80 %)
15 diff
(98.2 %id)
BG614394 embryonal carcinoma, testis .k 1 to 726 1 to 737       733/983
(74 %)
17 diff
(98.3 %id)
BG778401 adenocarcinoma, Prostate .k 1 to 633 1 to 634       634/634
(100 %)
2 diff
(99.7 %id)
BG779668 adenocarcinoma, Prostate .k 1 to 684 1 to 686       686/686
(100 %)
6 diff
(99.2 %id)
BG718811 testis .k 1 to 703 1 to 703       703/703
(100 %)
4 diff
(99.5 %id)
CB130421 Liver .k 1 to 470 1 to 469       469/471
(99 %)
2 diff
(99.6 %id)
AL037123 brain .k 2 to 710 32 to 743       712/743
(95 %)
18 diff
(97.6 %id)
BG504000 embryonal carcinoma, testis .k 2 to 713 1 to 713       713/714
(99 %)
8 diff
(98.9 %id)
BG493784 lung, mucoepidermoid carcinoma .k 2 to 735 1 to 736       736/736
(100 %)
5 diff
(99.4 %id)
BG531716 embryonal carcinoma, testis .k 2 to 661 1 to 662       662/869
(76 %)
15 diff
(98.3 %id)
BG531257 embryonal carcinoma, testis .k 2 to 683 1 to 684       684/684
(100 %)
7 diff
(99.0 %id)
BG611365 adenocarcinoma, Prostate .k 2 to 679 1 to 677       677/677
(100 %)
5 diff
(99.3 %id)
BG771212 adenocarcinoma, Prostate .k 2 to 714 41 to 752       712/752
(94 %)
16 diff
(97.9 %id)
CB108675 Liver .k 2 to 482 1 to 480       480/480
(100 %)
2 diff
(99.6 %id)
CB111535 Liver .k 2 to 603 1 to 602       602/602
(100 %)
1 diff
(99.9 %id)
CB116676 Liver .k 2 to 421 1 to 420       420/420
(100 %)
1 diff
(99.8 %id)
CB131017 Liver .k 2 to 539 1 to 538       538/538
(100 %)
0 diff
(100 %id)
CB141547 Liver .k 2 to 577 1 to 576       576/576
(100 %)
3 diff
(99.5 %id)
CB149154 Liver .k 2 to 603 1 to 602       602/602
(100 %)
2 diff
(99.7 %id)
CB148871 Liver .k 2 to 661 1 to 660       660/660
(100 %)
1 diff
(99.9 %id)
CB148485 Liver .k 2 to 525 1 to 524       524/524
(100 %)
2 diff
(99.7 %id)
BM753021 stomach .k 2 to 486 1 to 484       484/484
(100 %)
1 diff
(99.8 %id)
BM753803 stomach .k 2 to 548 1 to 547       547/547
(100 %)
4 diff
(99.3 %id)
BM773439 stomach .k 2 to 603 1 to 602       602/602
(100 %)
0 diff
(100 %id)
BM828674 Ascites, stomach .k 2 to 537 1 to 536       536/536
(100 %)
2 diff
(99.7 %id)
BM762780 lymph node, stomach .k 2 to 650 1 to 649       649/649
(100 %)
1 diff
(99.9 %id)
BM845111 lymph node, stomach .k 2 to 603 1 to 602       602/602
(100 %)
1 diff
(99.9 %id)
BM819476 stomach .k 2 to 532 1 to 529       529/529
(100 %)
2 diff
(99.7 %id)
DA037788   .k 3 to 561 2 to 561   capped   560/560
(100 %)
1 diff
(99.9 %id)
DA434176 tongue, tumor tissue .k 3 to 524 2 to 523   capped   522/522
(100 %)
0 diff
(100 %id)
BG528672 adenocarcinoma, Prostate .k 3 to 456 1 to 454       454/454
(100 %)
1 diff
(99.8 %id)
DA669402 esophagus .k 3 to 486 2 to 486   capped   485/485
(100 %)
1 diff
(99.8 %id)
DA914025   .k 3 to 565 2 to 564   capped   563/563
(100 %)
0 diff
(100 %id)
DB260979 uterus .k 3 to 551 2 to 549   capped   548/548
(100 %)
2 diff
(99.7 %id)
BM760827 lymph node, stomach .k 4 to 712 1 to 709       709/709
(100 %)
1 diff
(99.9 %id)
BM761148 lymph node, stomach .k 4 to 656 1 to 653       653/653
(100 %)
1 diff
(99.9 %id)
BG257542 embryonal carcinoma, cell line, testis .k 5 to 770 3 to 770       768/785
(97 %)
20 diff
(97.5 %id)
AU118842 whole embryo, mainly head .k 7 to 793 2 to 790   capped   789/822
(95 %)
3 diff
(99.7 %id)
BE908152 epithelioid carcinoma, Pancreas .k 7 to 668 1 to 665       665/945
(70 %)
13 diff
(98.7 %id)
CB141181 Liver .k 8 to 603 1 to 596       596/596
(100 %)
0 diff
(100 %id)
TI_57199214   .k 9 to 773 51 to 824       774/843
(91 %)
32 diff
(96.3 %id)
DA591998 lung .k 10 to 565 2 to 558   capped   557/557
(100 %)
1 diff
(99.9 %id)
BG403341 bladder, transitional cell papilloma, cell line .k 12 to 817 1 to 796       796/959
(83 %)
27 diff
(97.2 %id)
CD519110 White Matter .k 12 to 821 1 to 815 G207R K212X W213V I214D S215Q ...     815/848
(96 %)
9 diff
(99.0 %id)
BI092037 cervix .k 13 to 747 1 to 736       736/736
(100 %)
8 diff
(99.0 %id)
BQ277537 mixed (pool of 40 RNAs) .k 13 to 726 1 to 715       715/877
(81 %)
5 diff
(99.5 %id)
CN407787 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .k 14 to 610 8 to 604       597/604
(98 %)
6 diff
(99.1 %id)
CN407797 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .k 14 to 789 1 to 776   tiling clone,   776/776
(100 %)
3 diff
(99.7 %id)
ES310759 scalp interfollicular dermis, skin .k 14 to 649 1 to 637       637/637
(100 %)
9 diff
(98.6 %id)
BG423877 Kidney, renal cell adenocarcinoma .k 14 to 726 1 to 724       724/829
(87 %)
14 diff
(98.4 %id)
BG425608 Kidney, renal cell adenocarcinoma .k 14 to 780 1 to 777       777/824
(94 %)
20 diff
(97.6 %id)
BG468513 adenocarcinoma cell line, colon .k 14 to 793 1 to 780       780/791
(98 %)
7 diff
(99.2 %id)
BM043829 carcinoma, cell line, Prostate .k 14 to 711 1 to 697       697/697
(100 %)
1 diff
(99.9 %id)
CN407940 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .k 15 to 620 1 to 607       607/607
(100 %)
3 diff
(99.6 %id)
ES309574 occipital hair of pubic hypotrichosispatient, skin .k 15 to 495 19 to 498       480/534
(89 %)
11 diff
(98.0 %id)
BG117178 adenocarcinoma, cell line, Liver .k 15 to 666 1 to 661       659/804
(81 %)
11 diff
(98.7 %id)
BG336149 choriocarcinoma, placenta .k 15 to 784 1 to 768       768/1023
(75 %)
19 diff
(98.2 %id)
BG386796 adenocarcinoma cell line, colon .k 15 to 541 1 to 527       527/527
(100 %)
0 diff
(100 %id)
BG478392 melanotic melanoma, skin .k 15 to 726 1 to 719       717/951
(75 %)
9 diff
(99.1 %id)
CD514743 White Matter .k 15 to 821 1 to 808 D192* tiling clone,   808/861
(93 %)
11 diff
(98.8 %id)
CB118845 Liver .k 15 to 538 1 to 524       524/524
(100 %)
2 diff
(99.7 %id)
BG119283 adenocarcinoma, cell line, Liver .k 16 to 725 1 to 705       705/974
(72 %)
15 diff
(98.5 %id)
BU185927 epidermoid carcinoma, cell line, salivary gland .k 16 to 782 1 to 771       771/840
(91 %)
6 diff
(99.3 %id)
BQ934736 epidermoid carcinoma, cell line, lung .k 16 to 818 1 to 809       809/855
(94 %)
6 diff
(99.3 %id)
BM044535 carcinoma, cell line, Prostate .k 17 to 819 1 to 808   tiling clone,   808/817
(98 %)
9 diff
(98.9 %id)
CB119592 Liver .k 18 to 604 1 to 587       587/587
(100 %)
0 diff
(100 %id)
BU167347 melanotic melanoma, skin .k 19 to 817 1 to 804   tiling clone,   804/908
(88 %)
18 diff
(98.1 %id)
CD172388 White Matter .k 21 to 821 1 to 805 G207R P211S K212Q W213V I214D ... tiling clone,   805/862
(93 %)
9 diff
(99.0 %id)
BE730472 melanotic melanoma, skin .k 22 to 819 45 to 832       788/1000
(78 %)
22 diff
(97.8 %id)
BU162595 melanotic melanoma, cell line, skin .k 24 to 819 1 to 800       800/855
(93 %)
13 diff
(98.5 %id)
BQ958242 carcinoma, cell line, Prostate .k 26 to 819 35 to 831       797/1039
(76 %)
20 diff
(98.1 %id)
BE274995 melanotic melanoma, skin .k 42 to 821 1 to 782 D192*     782/849
(92 %)
16 diff
(98.2 %id)
BE745556 adenocarcinoma cell line, ovary .k 42 to 824 1 to 785 D200E A201R G202W V203S K204E ...     785/869
(90 %)
11 diff
(98.8 %id)
BF031673 hypernephroma, Kidney .l 1 to 591 1 to 589   tiling clone,   589/875
(67 %)
8 diff
(99.1 %id)
BU527780 epidermoid carcinoma, cell line, lung .l 61 to 1017 1 to 960 K132* tiling clone,   960/960
(100 %)
20 diff
(98.0 %id)
BG827313 muscle, rhabdomyosarcoma .l 67 to 684 1 to 630       630/822
(76 %)
21 diff
(97.5 %id)
BQ877396 ductal carcinoma, cell line, Pancreas .l 70 to 970 1 to 903   tiling clone,   903/904
(99 %)
7 diff
(99.3 %id)
BQ877272 ductal carcinoma, cell line, Pancreas .l 70 to 775 1 to 715       713/976
(73 %)
13 diff
(98.7 %id)
BQ687426 ductal carcinoma, cell line, Pancreas .l 70 to 931 1 to 873       873/910
(95 %)
19 diff
(98.0 %id)
BQ687919 ductal carcinoma, cell line, Pancreas .l 70 to 949 1 to 886   tiling clone,   886/887
(99 %)
17 diff
(98.1 %id)
BQ962397 epithelioid carcinoma cell line, Pancreas .l 70 to 923 1 to 862       862/862
(100 %)
11 diff
(98.8 %id)
BQ923761 epidermoid carcinoma, cell line, lung .l 70 to 955 1 to 889   tiling clone,   889/889
(100 %)
12 diff
(98.7 %id)
CN407916 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .l 73 to 636 1 to 564       564/564
(100 %)
0 diff
(100 %id)
CN407834 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .l 74 to 532 1 to 458       458/458
(100 %)
1 diff
(99.8 %id)
BU543244 carcinoma, cell line, Prostate .l 80 to 846 22 to 793       772/964
(80 %)
14 diff
(98.6 %id)
BQ945454 carcinoma, cell line, Prostate .l 83 to 920 1 to 849       849/882
(96 %)
28 diff
(96.9 %id)
BQ928778 carcinoma, cell line, Prostate .l 84 to 909 1 to 832       832/903
(92 %)
12 diff
(98.7 %id)
BM048855 carcinoma, cell line, Prostate .l 85 to 803 2 to 725       724/730
(99 %)
21 diff
(97.2 %id)
BM045921 carcinoma, cell line, Prostate .l 85 to 618 2 to 534       533/534
(99 %)
1 diff
(99.9 %id)
BE298921 muscle, rhabdomyosarcoma .l 87 to 516 1 to 430       430/431
(99 %)
2 diff
(99.6 %id)
BE298568 muscle, rhabdomyosarcoma .l 88 to 775 1 to 676       676/676
(100 %)
17 diff
(97.5 %id)
BQ943671 carcinoma, cell line, Prostate .l 89 to 914 35 to 862       828/865
(95 %)
10 diff
(98.9 %id)
AK309956 placenta .m 1 to 1075 2 to 1076 exact tiling clone,   1076/1076
(100 %)
0 diff
(100 %id)
BF880042 lung_tumor .m 536 to 857 44 to 361       318/361
(88 %)
6 diff
(98.4 %id)
BE142706 head_neck .m 743 to 1184 443 to 4     Submitted on the opposite strand 440/443
(99 %)
0 diff
(100 %id)
BF358530 lung_normal .m 806 to 1182 375 to 3       373/375
(99 %)
0 diff
(100 %id)
BX504015   .m 811 to 1416 1 to 606   tiling clone,   606/606
(100 %)
1 diff
(99.9 %id)
BF358531 lung_normal .m 818 to 1169 348 to 1       348/348
(100 %)
7 diff
(98.0 %id)
AW811585 stomach .m 1007 to 1155 149 to 1       149/149
(100 %)
0 diff
(100 %id)
BF349492 head_neck .m 1008 to 1191 19 to 201       183/201
(91 %)
6 diff
(97.1 %id)
BE148200 head_neck .m 1178 to 1403 1 to 226       226/241
(93 %)
8 diff
(96.7 %id)
TI_59390293   .n 1 to 704 238 to 944 K30T L50S E106Q K107T A123D ... tiling clone,   707/849
(83 %)
28 diff
(96.8 %id)
BF217374 brain, glioblastoma .o 1 to 718 1 to 728   tiling clone,   727/852
(85 %)
31 diff
(96.4 %id)
BQ225069 epithelioid carcinoma, Pancreas .o 55 to 633 1 to 581       581/989
(58 %)
8 diff
(99.2 %id)
CF127020 Chondrosarcoma Lung Metastasis cell lines, lung .o 69 to 787 1 to 718       718/718
(100 %)
4 diff
(99.5 %id)
TI_154190116   .o 69 to 993 48 to 958 E125X E136X V143G Q147S N148D ... tiling clone,   911/1014
(89 %)
14 diff
(98.7 %id)
DA913228   .p 1 to 572 2 to 574   tiling clone, capped   573/573
(100 %)
1 diff
(99.9 %id)
BP297769   .p 4 to 547 1 to 544       544/551
(98 %)
3 diff
(99.5 %id)
BU191278 ductal carcinoma, cell line, Pancreas .p 7 to 632 1 to 626       626/917
(68 %)
8 diff
(99.2 %id)
BE870041 adenocarcinoma, colon .p 16 to 733 29 to 745       717/865
(82 %)
17 diff
(98.1 %id)
BQ877183 ductal carcinoma, cell line, Pancreas .p 16 to 861 1 to 857   tiling clone,   855/865
(98 %)
16 diff
(98.2 %id)
BE568683 bladder, carcinoma, cell line .p 19 to 185 1 to 168       168/168
(100 %)
1 diff
(99.5 %id)
BQ718889 sympathetic trunk .p 19 to 872 1 to 855 R178X Q193P D194R A195C R196S tiling clone,   855/860
(99 %)
3 diff
(99.7 %id)
D82108   .p 134 to 503 1 to 369       369/369
(100 %)
3 diff
(99.2 %id)
D82119   .p 134 to 676 1 to 543       543/544
(99 %)
7 diff
(98.8 %id)
D82548   .p 135 to 676 1 to 542       542/542
(100 %)
4 diff
(99.3 %id)
CD638925 pooled .q 1 to 662 3 to 656   tiling clone,   656/701
(93 %)
18 diff
(97.5 %id)
DB246941   .q 1 to 556 2 to 559   capped   558/558
(100 %)
2 diff
(99.7 %id)
DB014149 esophageal, tumor tissue .q 3 to 572 2 to 571   capped   570/570
(100 %)
0 diff
(100 %id)
AA314369 colon .q 15 to 428 1 to 414       414/414
(100 %)
0 diff
(100 %id)
BE891681 melanotic melanoma, skin .q 33 to 658 1 to 628       628/943
(66 %)
6 diff
(99.4 %id)
CX165837 human embryonic stem cells differentiated toan early endodermal cell type .q 44 to 877 1 to 834   tiling clone,   834/834
(100 %)
0 diff
(100 %id)
BU166980 melanotic melanoma, skin .q 50 to 656 1 to 610       610/709
(86 %)
21 diff
(97.1 %id)
BM751499 Ascites, stomach .q 53 to 550 1 to 498       498/498
(100 %)
0 diff
(100 %id)
TI_59382146   .q 220 to 980 97 to 857 V146S Y147L K148Q E149G M150N ... tiling clone,   761/762
(99 %)
6 diff
(99.3 %id)
BE786947 large cell carcinoma, lung .r 1 to 558 1 to 558 exact tiling clone,   558/558
(100 %)
0 diff
(100 %id)
BM047101 carcinoma, cell line, Prostate .s 1 to 780 1 to 786 E149D M150T Y151L K152Y T153K ... tiling clone,   784/823
(95 %)
8 diff
(99.1 %id)
AK092006   .t 1 to 3527 2 to 3528   tiling clone, available from FLJ,   3528/3528
(100 %)
2 diff
(100.0 %id)
AX747305   .t 1 to 3527 2 to 3528       3528/3528
(100 %)
2 diff
(100.0 %id)
DA648046   .t 1 to 541 2 to 543   capped   542/542
(100 %)
1 diff
(99.9 %id)
DA857321 placenta .t 69 to 366 2 to 299   capped   298/298
(100 %)
0 diff
(100 %id)
AI337736 brain, tumor, 5 pooled (see description) .t 524 to 956 433 to 1       433/433
(100 %)
0 diff
(100 %id)
BI059885 uterus_tumor .t 864 to 1409 611 to 66       546/611
(89 %)
0 diff
(100 %id)
BG108556 Bone, osteosarcoma, cell line .t 952 to 1695 13 to 757       745/757
(98 %)
6 diff
(99.3 %id)
N34481.
matches multiple genes
melanocyte .t 1050 to 1517 470 to 1     also hits gene FNIP1andRAPGEF6 470/474
(99 %)
3 diff
(99.4 %id)
BF918071 uterus_tumor .t 1139 to 1409 337 to 66     Submitted on the opposite strand 272/337
(80 %)
0 diff
(100 %id)
AI355433 esophagus, squamous cell carcinoma .t 1216 to 1685 470 to 1       470/470
(100 %)
1 diff
(99.8 %id)
AW847031 colon .t 1786 to 1916 1 to 131   tiling clone,   131/131
(100 %)
1 diff
(99.3 %id)
DB321610   .t 3001 to 3527 528 to 1       528/528
(100 %)
1 diff
(99.9 %id)
TI_57164009   .u -11 to 713 26 to 748 exact     723/751
(96 %)
8 diff
(99.0 %id)
BI836982 pooled pancreas and spleen .u 1 to 713 7 to 718 exact tiling clone,   718/721
(99 %)
5 diff
(99.4 %id)
TI_57173373   .va 1 to 583 63 to 645 exact tiling clone,   583/645
(90 %)
6 diff
(99.1 %id)
CD693690 normal nasopharynx .vb 1 to 415 34 to 450 E61A T62D V63G I64D L65F ... tiling clone,   417/450
(92 %)
8 diff
(98.3 %id)
BG615124 embryonal carcinoma, testis .vc 1 to 613 1 to 631 P20T S22K A23C Y24I G25W ... tiling clone,   631/784
(80 %)
27 diff
(96.6 %id)
BM763605 myeloma .vd 1 to 560 1 to 560 exact tiling clone,   560/560
(100 %)
0 diff
(100 %id)
BU540693 large cell carcinoma, lung .ve 1 to 889 1 to 890 V120I tiling clone,   890/890
(100 %)
6 diff
(99.4 %id)
BF207478 bladder, carcinoma, cell line .vf 1 to 604 1 to 605 L60* tiling clone,   605/831
(72 %)
27 diff
(96.8 %id)
AI824118 lung, squamous cell carcinoma, poorlydifferentiated (4 pooled tumors, including primary andmetastatic) .vf 259 to 705 448 to 3   tiling clone,   446/448
(99 %)
0 diff
(100 %id)
BI027947 marrow .vf 460 to 596 137 to 1   tiling clone,   137/141
(97 %)
0 diff
(100 %id)
FN045839 breast carcinoma .vf 524 to 616 94 to 1     Submitted on the opposite strand 94/94
(100 %)
1 diff
(99.0 %id)
CD368861 Alveolar Macrophage, lung .vg 1 to 715 731 to 17 A23X tiling clone, AAA   715/715
(100 %)
2 diff
(99.8 %id)
R26331 placenta .vh 1 to 337 1 to 350 exact tiling clone, to resequence,   350/350
(100 %)
17 diff
(95.2 %id)
R26362 placenta .vh 1 to 342 1 to 345 exact tiling clone,   345/345
(100 %)
5 diff
(98.6 %id)
R26119 placenta .vh 1360 to 1793 438 to 4   tiling clone, to resequence,   435/443
(98 %)
1 diff
(99.8 %id)
R26148 placenta .vh 1360 to 1793 437 to 4   tiling clone,   434/437
(99 %)
0 diff
(100 %id)
DA033909   .vi 1 to 547 2 to 548 exact capped   547/552
(99 %)
2 diff
(99.7 %id)
DA652895   .vi 1 to 531 2 to 532 exact tiling clone, capped   531/531
(100 %)
1 diff
(99.9 %id)
DA661282   .vi 1 to 573 2 to 574 T31A tiling clone, capped   573/573
(100 %)
1 diff
(99.9 %id)
BU181294 epithelioid carcinoma, Pancreas .vi 17 to 898 1 to 897 L39F I63Y L64F Q65S L66C ... tiling clone,   897/907
(98 %)
31 diff
(96.6 %id)
AW190602 adenocarcinoma, Pancreas .vi 640 to 1089 456 to 6   tiling clone,   451/456
(98 %)
7 diff
(98.5 %id)
N42884 melanocyte .vi 879 to 1271 1 to 397   tiling clone,   397/397
(100 %)
8 diff
(98.0 %id)
BE141699 head_neck .vj 1 to 318 325 to 6   tiling clone, Submitted on the opposite strand 320/325
(98 %)
0 diff
(100 %id)
BU152009 sciatic nerve .vj 26 to 613 1 to 591   tiling clone,   591/955
(61 %)
26 diff
(97.3 %id)
AW998934 breast_normal .vj 322 to 821 15 to 513   tiling clone,   499/513
(97 %)
6 diff
(98.9 %id)
BG945384 amnion_normal .vj 519 to 1048 567 to 23 K2E tiling clone,   557/570
(97 %)
69 diff
(87.9 %id)
BQ350313 head_neck .vj 590 to 957 22 to 390   tiling clone,   369/409
(90 %)
6 diff
(98.6 %id)
BF217626 brain, glioblastoma .vk 1 to 461 1 to 461 C15V Y16L L17F N19K N20Q ...     461/487
(94 %)
13 diff
(97.4 %id)
BG779971 adenocarcinoma, Prostate .vk 1 to 476 1 to 481 S52R L53S K54Q K55E tiling clone,   481/628
(76 %)
9 diff
(98.6 %id)
BG770982 adenocarcinoma, Prostate .vk 1 to 454 1 to 453 N19K N20Q D21R T22Y G23W ... AAA   453/453
(100 %)
7 diff
(98.5 %id)
DW407651 Liver .vk 2 to 473 18 to 489 exact AAA   472/489
(96 %)
9 diff
(98.2 %id)
DW413655 Liver .vk 2 to 305 17 to 319       303/319
(94 %)
8 diff
(97.5 %id)
DA593305 lung .vk 7 to 538 2 to 533 P51S capped   532/538
(98 %)
2 diff
(99.7 %id)
AA290715 ovarian tumor, ovary .vk 19 to 438 1 to 420       420/420
(100 %)
0 diff
(100 %id)
AW015534   .vk 19 to 510 509 to 18 exact AAA   492/502
(98 %)
1 diff
(99.9 %id)
BG282346 melanotic melanoma, skin .vk 21 to 814 1 to 789 exact     789/873
(90 %)
18 diff
(98.0 %id)
BE727542 melanotic melanoma, skin .vk 42 to 686 1 to 660 V2W G3L G4V P5C K6S ...     660/966
(68 %)
13 diff
(98.7 %id)
BE729418 melanotic melanoma, skin .vk 42 to 841 1 to 795 exact     795/800
(99 %)
24 diff
(97.0 %id)
BE727489 melanotic melanoma, skin .vk 43 to 628 1 to 636 V2N G4L P5V K6C S7P ...     599/866
(69 %)
37 diff
(95.8 %id)
TI_149309833   .vk 48 to 908 935 to 83 L17X tiling clone, AAA   853/956
(89 %)
15 diff
(98.5 %id)
AW629494 pooled .vk 53 to 451 409 to 11 exact AAA   399/399
(100 %)
0 diff
(100 %id)
BU688196 lung .vk 206 to 908 722 to 20 L17X AAA   703/703
(100 %)
1 diff
(99.9 %id)
CA307033 Alveolar Macrophage, lung .vk 293 to 908 635 to 20   AAA   616/616
(100 %)
2 diff
(99.7 %id)
BF056829 pooled germ cell tumors .vk 335 to 905 576 to 6       571/576
(99 %)
0 diff
(100 %id)
AI638078 pooled germ cell tumors .vk 509 to 905 402 to 6       397/402
(98 %)
0 diff
(100 %id)
AA283739 ovarian tumor, ovary .vk 563 to 904 342 to 1       342/342
(100 %)
1 diff
(99.8 %id)
FN046222 breast carcinoma .vk 691 to 774 1 to 84       84/85
(98 %)
2 diff
(97.7 %id)
BX480743   .vl-u 1 to 606 1 to 609 L14F E15T S16K A17V E18L ... tiling clone,   609/609
(100 %)
3 diff
(99.6 %id)
BE184778 head_neck .vl-u 192 to 540 1 to 348       348/348
(100 %)
6 diff
(98.3 %id)
BE184833 head_neck .vl-u 196 to 552 6 to 361       356/361
(98 %)
6 diff
(98.4 %id)
BE184769 head_neck .vl-u 387 to 756 366 to 1   tiling clone, Submitted on the opposite strand 366/366
(100 %)
8 diff
(97.9 %id)
BE184757 head_neck .vl-u 517 to 759 252 to 5   tiling clone, Submitted on the opposite strand 248/257
(96 %)
0 diff
(100 %id)
BE568751 bladder, carcinoma, cell line .vm 1 to 705 4 to 703 C12Y tiling clone,   703/732
(96 %)
37 diff
(95.0 %id)
CA306551 Alveolar Macrophage, lung .vm 31 to 743 731 to 19 exact tiling clone, AAA   713/713
(100 %)
1 diff
(99.9 %id)
AI874379 ovary, tumor, 5 pooled (see description) .vm 373 to 741 369 to 1   tiling clone,   369/369
(100 %)
1 diff
(99.8 %id)
DA613839   .vn 1 to 577 2 to 578 exact tiling clone, capped   577/577
(100 %)
4 diff
(99.4 %id)
CV381466 breast_normal .vn 28 to 411 422 to 40 K18I   Submitted on the opposite strand 383/431
(88 %)
0 diff
(100 %id)
AI635356 pooled germ cell tumors .vn 42 to 384 343 to 1 exact tiling clone,   343/343
(100 %)
0 diff
(100 %id)
AW237138 pooled germ cell tumors .vn 42 to 384 343 to 1 exact     343/343
(100 %)
0 diff
(100 %id)
AI917392 pooled germ cell tumors .vn 46 to 384 340 to 1 exact     340/343
(99 %)
1 diff
(99.8 %id)
DA723389   .vo 1 to 566 2 to 567 exact tiling clone, capped   566/566
(100 %)
0 diff
(100 %id)
BX474426   .vo 2 to 428 10 to 436 A35S     427/436
(97 %)
9 diff
(98.0 %id)
DB260783 uterus .vp 1 to 561 2 to 563 exact tiling clone, capped   562/562
(100 %)
2 diff
(99.7 %id)
AU099763   .vq 1 to 288 13 to 300       288/300
(96 %)
9 diff
(97.0 %id)
DB019089 esophageal, tumor tissue .vq 1 to 520 2 to 522 exact tiling clone, capped   521/521
(100 %)
1 diff
(99.9 %id)
DB196010 trachea .vr 1 to 513 2 to 514 exact tiling clone, capped   513/513
(100 %)
1 diff
(99.9 %id)
AW995678 breast_normal .vs-u 1 to 430 11 to 439 F2L F3L F4L P5A P6L ... tiling clone,   429/439
(97 %)
6 diff
(98.7 %id)
BF380729 uterus_tumor .vt-u 1 to 403 33 to 434 V39A F40V tiling clone,   402/434
(92 %)
6 diff
(98.7 %id)
BF089231 head_neck .vu 1 to 202 134 to 335 exact tiling clone,   202/335
(60 %)
7 diff
(98.0 %id)
BM693023.
matches multiple genes
eye, Retina Foveal and Macular P1.a-u 788 to 1317 1 to 547     also hits gene ANXA2P1 547/550
(99 %)
24 diff
(95.7 %id)
BE273261.
matches multiple genes
Kidney, renal cell adenocarcinoma P2.a-u 38 to 741 1 to 701     also hits gene ANXA2P2 701/710
(98 %)
31 diff
(95.7 %id)
BM846945.
matches multiple genes
myeloma P2.a-u 42 to 145 1 to 104     also hits gene ANXA2P2 104/104
(100 %)
0 diff
(100 %id)
AA302389.
matches multiple genes
aorta P2.a-u 423 to 592 1 to 170     also hits gene ANXA2P2 170/170
(100 %)
0 diff
(100 %id)
AA304360.
matches multiple genes
aorta P2.a-u 434 to 608 1 to 175     also hits gene ANXA2P2 175/175
(100 %)
0 diff
(100 %id)
AA155921.
matches multiple genes
  P2.a-u 439 to 995 1 to 552     also hits gene ANXA2P2 552/591
(93 %)
16 diff
(97.3 %id)
453 other accessions, mainly redundant or of lesser quality, also belong to this gene but are not reported.
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d, .e, .f, .g, .h, .i, .j, .k, .l, .m, .n, .o, .p, .q, .r, .s, .t, .u, .va, .vb, .vc, .vd, .ve, .vf, .vg, .vh, .vi, .vj, .vk, .vl-u, .vm, .vn, .vo, .vp, .vq, .vr, .vs-u, .vt-u, .vu Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes DCI